Fabio Ciceri
#125,340
Most Influential Person Now
Researcher
Fabio Ciceri's AcademicInfluence.com Rankings
Fabio Cicericomputer-science Degrees
Computer Science
#5232
World Rank
#5526
Historical Rank
Computational Linguistics
#681
World Rank
#693
Historical Rank
Machine Learning
#1307
World Rank
#1327
Historical Rank
Artificial Intelligence
#1545
World Rank
#1574
Historical Rank
Download Badge
Computer Science
Fabio Ciceri's Degrees
- PhD Computer Science University of Milan
- Masters Computer Science University of Milan
- Bachelors Computer Science University of Milan
Similar Degrees You Can Earn
Why Is Fabio Ciceri Influential?
(Suggest an Edit or Addition)Fabio Ciceri's Published Works
Number of citations in a given year to any of this author's works
Total number of citations to an author for the works they published in a given year. This highlights publication of the most important work(s) by the author
Published Works
- Autoantibodies against type I IFNs in patients with life-threatening COVID-19 (2020) (1744)
- Retinoic acid and arsenic trioxide for acute promyelocytic leukemia. (2013) (1143)
- Lentiviral Hematopoietic Stem Cell Gene Therapy Benefits Metachromatic Leukodystrophy (2013) (1030)
- Gene therapy for immunodeficiency due to adenosine deaminase deficiency. (2009) (926)
- Anxiety and depression in COVID-19 survivors: Role of inflammatory and clinical predictors (2020) (913)
- Lentiviral Hematopoietic Stem Cell Gene Therapy in Patients with Wiskott-Aldrich Syndrome (2013) (812)
- Monocyte-derived IL-1 and IL-6 are differentially required for cytokine-release syndrome and neurotoxicity due to CAR T cells (2018) (799)
- Interleukin-1 blockade with high-dose anakinra in patients with COVID-19, acute respiratory distress syndrome, and hyperinflammation: a retrospective cohort study (2020) (779)
- Gilteritinib or Chemotherapy for Relapsed or Refractory FLT3-Mutated AML. (2019) (585)
- Infusion of suicide-gene-engineered donor lymphocytes after family haploidentical haemopoietic stem-cell transplantation for leukaemia (the TK007 trial): a non-randomised phase I-II study. (2009) (446)
- IL-7 and IL-15 instruct the generation of human memory stem T cells from naive precursors. (2013) (430)
- Editing T cell specificity towards leukemia by zinc finger nucleases and lentiviral gene transfer (2012) (424)
- Microvascular COVID-19 lung vessels obstructive thromboinflammatory syndrome (MicroCLOTS): an atypical acute respiratory distress syndrome working hypothesis. (2020) (417)
- Complement as a target in COVID-19? (2020) (415)
- Improved risk classification for risk-specific therapy based on the molecular study of minimal residual disease (MRD) in adult acute lymphoblastic leukemia (ALL). (2009) (396)
- Revised diagnosis and severity criteria for sinusoidal obstruction syndrome/veno-occlusive disease in adult patients: a new classification from the European Society for Blood and Marrow Transplantation (2016) (332)
- Lentiviral haemopoietic stem-cell gene therapy in early-onset metachromatic leukodystrophy: an ad-hoc analysis of a non-randomised, open-label, phase 1/2 trial (2016) (322)
- Sinusoidal obstruction syndrome/veno-occlusive disease: current situation and perspectives—a position statement from the European Society for Blood and Marrow Transplantation (EBMT) (2015) (277)
- CD44v6-targeted T cells mediate potent antitumor effects against acute myeloid leukemia and multiple myeloma. (2013) (276)
- A survey of fully haploidentical hematopoietic stem cell transplantation in adults with high-risk acute leukemia: a risk factor analysis of outcomes for patients in remission at transplantation. (2008) (272)
- Autoantibodies neutralizing type I IFNs are present in ~4% of uninfected individuals over 70 years old and account for ~20% of COVID-19 deaths (2021) (257)
- The first case of COVID-19 treated with the complement C3 inhibitor AMY-101 (2020) (245)
- Neutralizing antibody responses to SARS-CoV-2 in symptomatic COVID-19 is persistent and critical for survival (2021) (244)
- Autologous stem cell transplantation in the treatment of systemic sclerosis: report from the EBMT/EULAR Registry (2004) (244)
- Chemotherapy-phased imatinib pulses improve long-term outcome of adult patients with Philadelphia chromosome-positive acute lymphoblastic leukemia: Northern Italy Leukemia Group protocol 09/00. (2010) (238)
- Early predictors of clinical outcomes of COVID-19 outbreak in Milan, Italy (2020) (221)
- Characteristics, treatment, outcomes and cause of death of invasively ventilated patients with COVID-19 ARDS in Milan, Italy. (2020) (215)
- Interleukin-6 blockade with sarilumab in severe COVID-19 pneumonia with systemic hyperinflammation: an open-label cohort study (2020) (206)
- The potential immunogenicity of the TK suicide gene does not prevent full clinical benefit associated with the use of TK-transduced donor lymphocytes in HSCT for hematologic malignancies. (2007) (206)
- Retroviral vector integration deregulates gene expression but has no consequence on the biology and function of transplanted T cells (2006) (202)
- Persistent psychopathology and neurocognitive impairment in COVID-19 survivors: Effect of inflammatory biomarkers at three-month follow-up (2021) (199)
- Secondary infections in patients hospitalized with COVID-19: incidence and predictive factors (2020) (194)
- Immune signature drives leukemia escape and relapse after hematopoietic cell transplantation (2019) (194)
- Prophylaxis and management of graft versus host disease after stem-cell transplantation for haematological malignancies: updated consensus recommendations of the European Society for Blood and Marrow Transplantation. (2020) (193)
- Herpes simplex virus thymidine kinase gene transfer for controlled graft-versus-host disease and graft-versus-leukemia: clinical follow-up and improved new vectors. (1998) (189)
- Definition of GvHD-free, relapse-free survival for registry-based studies: an ALWP–EBMT analysis on patients with AML in remission (2016) (189)
- Sorafenib promotes graft-versus-leukemia activity in mice and humans through IL-15 production in FLT3-ITD-mutant leukemia cells (2018) (187)
- A T-cell epitope encoded by a subset of HLA-DPB1 alleles determines nonpermissive mismatches for hematologic stem cell transplantation. (2003) (185)
- Clinical Effects of Driver Somatic Mutations on the Outcomes of Patients With Myelodysplastic Syndromes Treated With Allogeneic Hematopoietic Stem-Cell Transplantation. (2016) (183)
- Comparison of outcomes after unrelated cord blood and unmanipulated haploidentical stem cell transplantation in adults with acute leukemia (2015) (181)
- Management of adults and children undergoing chimeric antigen receptor T-cell therapy: best practice recommendations of the European Society for Blood and Marrow Transplantation (EBMT) and the Joint Accreditation Committee of ISCT and EBMT (JACIE) (2019) (177)
- Loss of mismatched HLA in leukemia after stem-cell transplantation. (2009) (175)
- Update on the safety and efficacy of retroviral gene therapy for immunodeficiency due to adenosine deaminase deficiency. (2016) (174)
- GM-CSF blockade with mavrilimumab in severe COVID-19 pneumonia and systemic hyperinflammation: a single-centre, prospective cohort study (2020) (173)
- Fast reshaping of intensive care unit facilities in a large metropolitan hospital in Milan, Italy: facing the COVID-19 pandemic emergency (2020) (172)
- Antitumor effects of HSV-TK-engineered donor lymphocytes after allogeneic stem-cell transplantation. (2007) (171)
- In Vivo Tracking of Human Hematopoiesis Reveals Patterns of Clonal Dynamics during Early and Steady-State Reconstitution Phases (2016) (168)
- Safety of retroviral gene marking with a truncated NGF receptor (2003) (168)
- Complement C3 vs C5 inhibition in severe COVID-19: Early clinical findings reveal differential biological efficacy (2020) (167)
- IL-7 and IL-15 allow the generation of suicide gene-modified alloreactive self-renewing central memory human T lymphocytes. (2009) (165)
- Human IL2RA null mutation mediates immunodeficiency with lymphoproliferation and autoimmunity (2013) (162)
- Allogeneic transplantation improves the overall and progression-free survival of Hodgkin lymphoma patients relapsing after autologous transplantation: a retrospective study based on the time of HLA typing and donor availability. (2008) (159)
- Intrabone hematopoietic stem cell gene therapy for adult and pediatric patients affected by transfusion-dependent ß-thalassemia (2019) (156)
- Reduced-intensity conditioning followed by allografting of hematopoietic cells can produce clinical and molecular remissions in patients with poor-risk hematologic malignancies. (2002) (156)
- Molecular diagnosis of sepsis in neutropenic patients with haematological malignancies. (2008) (155)
- Risk factors for the development of secondary malignancy after high-dose chemotherapy and autograft, with or without rituximab: a 20-year retrospective follow-up study in patients with lymphoma. (2011) (148)
- Tumour-derived PGD2 and NKp30-B7H6 engagement drives an immunosuppressive ILC2-MDSC axis (2017) (146)
- Relapse of AML after hematopoietic stem cell transplantation: methods of monitoring and preventive strategies. A review from the ALWP of the EBMT (2016) (144)
- Pulmonary hypertension and right ventricular involvement in hospitalised patients with COVID-19 (2020) (143)
- The European Society for Blood and Marrow Transplantation (EBMT) Consensus Guidelines for the Detection and Treatment of Donor-specific Anti-HLA Antibodies (DSA) in Haploidentical Hematopoietic Cell Transplantation (2018) (141)
- Eosinophils from Physiology to Disease: A Comprehensive Review (2018) (140)
- Anthracycline-induced cardiotoxicity: A multicenter randomised trial comparing two strategies for guiding prevention with enalapril: The International CardioOncology Society-one trial. (2018) (140)
- The suicide gene therapy challenge: how to improve a successful gene therapy approach. (2007) (138)
- miR-126 Regulates Distinct Self-Renewal Outcomes in Normal and Malignant Hematopoietic Stem Cells (2016) (135)
- Flotetuzumab as Salvage Immunotherapy for Refractory Acute Myeloid Leukemia. (2020) (134)
- Nonpermissive HLA-DPB1 disparity is a significant independent risk factor for mortality after unrelated hematopoietic stem cell transplantation. (2009) (130)
- NK cell recovery after haploidentical HSCT with posttransplant cyclophosphamide: dynamics and clinical implications. (2018) (130)
- Immunologic potential of donor lymphocytes expressing a suicide gene for early immune reconstitution after hematopoietic T-cell-depleted stem cell transplantation. (2003) (130)
- Immunological Outcome in Haploidentical-HSC Transplanted Patients Treated with IL-10-Anergized Donor T Cells (2013) (128)
- Residual clinical damage after COVID-19: A retrospective and prospective observational cohort study (2020) (128)
- Hypocalcemia is highly prevalent and predicts hospitalization in patients with COVID-19 (2020) (127)
- Infections by carbapenem-resistant Klebsiella pneumoniae in SCT recipients: a nationwide retrospective survey from Italy (2015) (127)
- Interleukin-1 and interleukin-6 inhibition compared with standard management in patients with COVID-19 and hyperinflammation: a cohort study (2021) (127)
- Infliximab treatment for steroid-refractory acute graft-versus-host disease. (2004) (127)
- COVID-19 infection in adult patients with hematological malignancies: a European Hematology Association Survey (EPICOVIDEHA) (2021) (126)
- Lentiviral haemopoietic stem/progenitor cell gene therapy for treatment of Wiskott-Aldrich syndrome: interim results of a non-randomised, open-label, phase 1/2 clinical study (2019) (125)
- Suicide gene therapy of graft-versus-host disease induced by central memory human T lymphocytes. (2005) (125)
- Temporal, quantitative, and functional characteristics of single-KIR-positive alloreactive natural killer cell recovery account for impaired graft-versus-leukemia activity after haploidentical hematopoietic stem cell transplantation. (2008) (124)
- Allogeneic transplantation following a reduced-intensity conditioning regimen in relapsed/refractory peripheral T-cell lymphomas: long-term remissions and response to donor lymphocyte infusions support the role of a graft-versus-lymphoma effect (2012) (122)
- Use of tyrosine kinase inhibitors to prevent relapse after allogeneic hematopoietic stem cell transplantation for patients with Philadelphia chromosome–positive acute lymphoblastic leukemia: A position statement of the Acute Leukemia Working Party of the European Society for Blood and Marrow Transpl (2016) (122)
- Bone marrow versus mobilized peripheral blood stem cells in haploidentical transplants using posttransplantation cyclophosphamide (2018) (117)
- Generation of human memory stem T cells after haploidentical T-replete hematopoietic stem cell transplantation. (2015) (112)
- COVID-19 and stem cell transplantation; results from an EBMT and GETH multicenter prospective survey (2021) (111)
- Post-transplantation Cyclophosphamide and Sirolimus after Haploidentical Hematopoietic Stem Cell Transplantation Using a Treosulfan-based Myeloablative Conditioning and Peripheral Blood Stem Cells. (2015) (107)
- Sirolimus-based graft-versus-host disease prophylaxis promotes the in vivo expansion of regulatory T cells and permits peripheral blood stem cell transplantation from haploidentical donors (2014) (106)
- miR-126 Regulates Distinct Self-Renewal Outcomes in Normal and Malignant Hematopoietic Stem Cells (2016) (102)
- Post-transplant cyclophosphamide versus anti-thymocyte globulin as graft- versus-host disease prophylaxis in haploidentical transplant (2017) (98)
- Improving the safety of cell therapy with the TK-suicide gene (2015) (98)
- Prediction of Allogeneic Hematopoietic Stem-Cell Transplantation Mortality 100 Days After Transplantation Using a Machine Learning Algorithm: A European Group for Blood and Marrow Transplantation Acute Leukemia Working Party Retrospective Data Mining Study. (2015) (97)
- Health related quality of life in Middle Eastern children with beta-thalassemia (2012) (94)
- Bone marrow central memory and memory stem T-cell exhaustion in AML patients relapsing after HSCT (2019) (94)
- Outcome of patients with distinct molecular genotypes and cytogenetically normal AML after allogeneic transplantation. (2015) (90)
- Hematopoietic stem cell transplantation for adults with Philadelphia chromosome-negative acute lymphoblastic leukemia in first remission: a position statement of the European Working Group for Adult Acute Lymphoblastic Leukemia (EWALL) and the Acute Leukemia Working Party of the European Society for (2018) (90)
- Incidence, risk factors and clinical outcome of leukemia relapses with loss of the mismatched HLA after partially incompatible hematopoietic stem cell transplantation (2014) (89)
- The impact of amino acid variability on alloreactivity defines a functional distance predictive of permissive HLA-DPB1 mismatches in hematopoietic stem cell transplantation. (2015) (89)
- Intra‐arterial transplantation of HLA‐matched donor mesoangioblasts in Duchenne muscular dystrophy (2015) (88)
- Autologous Pancreatic Islet Transplantation in Human Bone Marrow (2013) (87)
- Incidence, Risk Factors and Outcome of Pre-engraftment Gram-Negative Bacteremia After Allogeneic and Autologous Hematopoietic Stem Cell Transplantation: An Italian Prospective Multicenter Survey (2017) (87)
- High Doses of Antimetabolites Followed by High-Dose Sequential Chemoimmunotherapy and Autologous Stem-Cell Transplantation in Patients With Systemic B-Cell Lymphoma and Secondary CNS Involvement: Final Results of a Multicenter Phase II Trial. (2015) (84)
- Combined Treatment with High-Dose Methotrexate, Vincristine and Procarbazine, without Intrathecal Chemotherapy, Followed by Consolidation Radiotherapy for Primary Central Nervous System Lymphoma in Immunocompetent Patients (2001) (83)
- Anti-thymocyte globulin as graft-versus-host disease prevention in the setting of allogeneic peripheral blood stem cell transplantation: a review from the Acute Leukemia Working Party of the European Society for Blood and Marrow Transplantation (2017) (82)
- The European Society for Blood and Marrow Transplantation (EBMT) consensus recommendations for donor selection in haploidentical hematopoietic cell transplantation (2019) (82)
- Severely low testosterone in males with COVID‐19: A case‐control study (2021) (82)
- COVID-19 survival associates with the immunoglobulin response to the SARS-CoV-2 spike Receptor Binding Domain. (2020) (80)
- A novel self-lipid antigen targets human T cells against CD1c+ leukemias (2014) (80)
- Inherited perforin and Fas mutations in a patient with autoimmune lymphoproliferative syndrome and lymphoma. (2004) (79)
- Tracking genetically engineered lymphocytes long-term reveals the dynamics of T cell immunological memory (2015) (78)
- A plastic SQSTM1/p62-dependent autophagic reserve maintains proteostasis and determines proteasome inhibitor susceptibility in multiple myeloma cells (2015) (78)
- Initial chest radiographs and artificial intelligence (AI) predict clinical outcomes in COVID-19 patients: analysis of 697 Italian patients (2020) (77)
- Acute promyelocytic leukemia following mitoxantrone as single agent for the treatment of multiple sclerosis (1998) (76)
- Raman spectroscopy uncovers biochemical tissue-related features of extracellular vesicles from mesenchymal stromal cells (2017) (74)
- PTCy-based haploidentical vs matched related or unrelated donor reduced-intensity conditioning transplant for DLBCL. (2019) (73)
- Clinical tolerance in allogeneic hematopoietic stem cell transplantation (2011) (72)
- A survey on unmanipulated haploidentical hematopoietic stem cell transplantation in adults with acute leukemia (2014) (72)
- Antibody response to multiple antigens of SARS-CoV-2 in patients with diabetes: an observational cohort study (2020) (72)
- Clinical practice recommendation on hematopoietic stem cell transplantation for acute myeloid leukemia patients with FLT3-internal tandem duplication: a position statement from the Acute Leukemia Working Party of the European Society for Blood and Marrow Transplantation (2020) (72)
- Is there a stronger graft-versus-leukemia effect using HLA-haploidentical donors compared with HLA-identical siblings? (2016) (71)
- Autologous stem cell transplantation as rescue therapy in malignant forms of multiple sclerosis (2005) (71)
- Haploidentical hematopoietic cell transplantation for adult acute myeloid leukemia: a position statement from the Acute Leukemia Working Party of the European Society for Blood and Marrow Transplantation (2017) (71)
- A comparison between allogeneic stem cell transplantation from unmanipulated haploidentical and unrelated donors in acute leukemia (2017) (71)
- Allogeneic hematopoietic stem cell transplantation in patients with diffuse large B cell lymphoma relapsed after autologous stem cell transplantation: A GITMO study (2012) (71)
- Alternative donors for allogeneic hematopoietic stem cell transplantation in poor-risk AML in CR1. (2017) (69)
- Achieving Molecular Remission before Allogeneic Stem Cell Transplantation in Adult Patients with Philadelphia Chromosome-Positive Acute Lymphoblastic Leukemia: Impact on Relapse and Long-Term Outcome. (2016) (69)
- Rituximab improves the efficacy of high-dose chemotherapy with autograft for high-risk follicular and diffuse large B-cell lymphoma: a multicenter Gruppo Italiano Terapie Innnovative nei linfomi survey. (2008) (67)
- Extreme heterogeneity of myeloablative total body irradiation techniques in clinical practice: A survey of the Acute Leukemia Working Party of the European Group for Blood and Marrow Transplantation (2014) (67)
- Classification and Personalized Prognostic Assessment on the Basis of Clinical and Genomic Features in Myelodysplastic Syndromes (2021) (66)
- Intra‐arterial transplantation of HLA‐matched donor mesoangioblasts in Duchenne muscular dystrophy (2016) (66)
- Management of Adults and Children receiving CAR T-cell therapy: 2021 Best Practice Recommendations of the European Society for Blood and Marrow Transplantation (EBMT) and the Joint Accreditation Committee of ISCT and EBMT (JACIE) and the European Haematology Association (EHA) (2021) (65)
- Clinical impact of suicide gene therapy in allogeneic hematopoietic stem cell transplantation. (2010) (64)
- The amyloidogenic light chain is a stressor that sensitizes plasma cells to proteasome inhibitor toxicity. (2017) (64)
- Treosulfan or busulfan plus fludarabine as conditioning treatment before allogeneic haemopoietic stem cell transplantation for older patients with acute myeloid leukaemia or myelodysplastic syndrome (MC-FludT.14/L): a randomised, non-inferiority, phase 3 trial. (2019) (64)
- Central nervous system dissemination in immunocompetent patients with aggressive lymphomas: incidence, risk factors and therapeutic options (2009) (64)
- Changes in the immune responses against human herpesvirus-8 in the disease course of posttransplant Kaposi sarcoma. (2008) (63)
- Matching for the nonconventional MHC-I MICA gene significantly reduces the incidence of acute and chronic GVHD. (2016) (63)
- Prophylactic donor lymphocyte infusion after allogeneic stem cell transplantation in acute leukaemia – a matched pair analysis by the Acute Leukaemia Working Party of EBMT (2018) (61)
- Different molecular levels of post-induction minimal residual disease may predict hematopoietic stem cell transplantation outcome in adult Philadelphia-negative acute lymphoblastic leukemia (2014) (60)
- Unmanipulated haploidentical stem cell transplantation in adults with acute lymphoblastic leukemia: a study on behalf of the Acute Leukemia Working Party of the EBMT (2017) (59)
- Prospective assessment of NGS-detectable mutations in CML patients with non-optimal response: the NEXT-in-CML study. (2019) (57)
- Candidemia in COVID-19 patients: incidence and characteristics in a prospective cohort compared to historical non-COVID-19 controls (2020) (57)
- Extracellular NGFR Spacers Allow Efficient Tracking and Enrichment of Fully Functional CAR-T Cells Co-Expressing a Suicide Gene (2018) (57)
- Effect of age and previous autologous transplantation on nonrelapse mortality and survival in patients treated with reduced-intensity conditioning and allografting for advanced hematologic malignancies. (2005) (57)
- NY-ESO-1 TCR single edited stem and central memory T cells to treat multiple myeloma without graft-versus-host disease. (2017) (56)
- Redefining and measuring transplant conditioning intensity in current era: a study in acute myeloid leukemia patients (2020) (56)
- Design and Validation of an Augmented Hematopoietic Cell Transplantation-Comorbidity Index Comprising Pretransplant Ferritin, Albumin, and Platelet Count for Prediction of Outcomes after Allogeneic Transplantation. (2015) (56)
- Modulation of GvHD by suicide-gene transduced donor T lymphocytes: clinical applications in mismatched transplantation. (2005) (55)
- Quantitative muscle strength assessment in duchenne muscular dystrophy: longitudinal study and correlation with functional measures (2011) (55)
- Allogeneic stem cell transplantation for acute myeloid leukemia (2010) (54)
- Impact of conditioning intensity in T-replete haplo-identical stem cell transplantation for acute leukemia: a report from the acute leukemia working party of the EBMT (2016) (54)
- Post-remission strategies for the prevention of relapse following allogeneic hematopoietic cell transplantation for high-risk acute myeloid leukemia: expert review from the Acute Leukemia Working Party of the European Society for Blood and Marrow Transplantation (2018) (54)
- Prevalence, Characteristics, Risk Factors, and Outcomes of Invasively Ventilated COVID-19 Patients with Acute Kidney Injury and Renal Replacement Therapy (2020) (54)
- Droplet digital polymerase chain reaction for DNMT3A and IDH1/2 mutations to improve early detection of acute myeloid leukemia relapse after allogeneic hematopoietic stem cell transplantation (2016) (53)
- Prospective assessment of health-related quality of life in pediatric patients with beta-thalassemia following hematopoietic stem cell transplantation. (2011) (52)
- Primary prophylaxis of invasive fungal diseases in allogeneic stem cell transplantation: revised recommendations from a consensus process by Gruppo Italiano Trapianto Midollo Osseo (GITMO). (2014) (52)
- Autologous hematopoietic stem cell transplantation in neuromyelitis optica: A registry study of the EBMT Autoimmune Diseases Working Party (2015) (52)
- HLA matching affects clinical outcome of adult patients undergoing haematopoietic SCT from unrelated donors: a study from the Gruppo Italiano Trapianto di Midollo Osseo and Italian Bone Marrow Donor Registry (2009) (51)
- Clearance of circulating activated platelets in polycythemia vera and essential thrombocythemia. (2011) (51)
- T-cell suicide gene therapy prompts thymic renewal in adults after hematopoietic stem cell transplantation. (2012) (51)
- Frequency and targeted detection of HLA-DPB1 T cell epitope disparities relevant in unrelated hematopoietic stem cell transplantation. (2007) (51)
- Prognostic factors for survival in patients with advanced renal cell carcinoma undergoing nonmyeloablative allogeneic stem cell transplantation (2005) (51)
- Haploidentical transplantation in patients with acquired aplastic anemia (2013) (50)
- Pre-emptive treatment of acute GVHD: a randomized multicenter trial of rabbit anti-thymocyte globulin, given on day+7 after alternative donor transplants (2010) (50)
- Post-COVID-19 follow-up clinic: depicting chronicity of a new disease (2020) (49)
- miRNA-126 Orchestrates an Oncogenic Program in B Cell Precursor Acute Lymphoblastic Leukemia. (2016) (49)
- Peripheral blood lymphocytes genetically modified to express the self/tumor antigen MAGE-A3 induce antitumor immune responses in cancer patients. (2009) (49)
- Absence of VOD in paediatric thalassaemic HSCT recipients using defibrotide prophylaxis and intravenous Busulphan (2009) (47)
- Frequent and Persistent Salivary Gland Ectasia and Oral Disease After COVID-19 (2021) (47)
- High incidence of severe cyclosporine neurotoxicity in children affected by haemoglobinopaties undergoing myeloablative haematopoietic stem cell transplantation: early diagnosis and prompt intervention ameliorates neurological outcome (2010) (47)
- Primary brain CD30+ ALK1+ anaplastic large cell lymphoma ('ALKoma'): the first case with a combination of 'not common' variants. (2002) (46)
- Donor age determines outcome in acute leukemia patients over 40 undergoing haploidentical hematopoietic cell transplantation (2018) (46)
- High-Definition Mapping of Retroviral Integration Sites Defines the Fate of Allogeneic T Cells After Donor Lymphocyte Infusion (2010) (46)
- TCR Redirected T Cells for Cancer Treatment: Achievements, Hurdles, and Goals (2020) (46)
- Second hematopoietic SCT in patients with thalassemia recurrence following rejection of the first graft (2008) (45)
- Clinical applications of donor lymphocyte infusion from an HLA-haploidentical donor: consensus recommendations from the Acute Leukemia Working Party of the EBMT (2019) (45)
- Clinical presentation and management practice of systemic mastocytosis. A survey on 460 Italian patients (2016) (44)
- Prophylactic, preemptive, and curative treatment for sinusoidal obstruction syndrome/veno-occlusive disease in adult patients: a position statement from an international expert group (2019) (44)
- Preliminary Results of a Phase 1 Study of Flotetuzumab, a CD123 x CD3 Bispecific Dart® Protein, in Patients with Relapsed/Refractory Acute Myeloid Leukemia and Myelodysplastic Syndrome (2017) (44)
- Second reduced intensity conditioning allogeneic transplant as a rescue strategy for acute leukaemia patients who relapse after an initial RIC allogeneic transplantation: analysis of risk factors and treatment outcomes (2016) (44)
- Management of carbapenem resistant Klebsiella pneumoniae infections in stem cell transplant recipients: an Italian multidisciplinary consensus statement (2015) (43)
- Next-Generation Manufacturing Protocols Enriching TSCM CAR T Cells Can Overcome Disease-Specific T Cell Defects in Cancer Patients (2020) (43)
- Autologous Islet Transplantation in Patients Requiring Pancreatectomy: A Broader Spectrum of Indications Beyond Chronic Pancreatitis (2016) (43)
- Longitudinal MRI quantification of muscle degeneration in Duchenne muscular dystrophy (2016) (42)
- Conditioning intensity in middle-aged patients with AML in first CR: no advantage for myeloablative regimens irrespective of the risk group–an observational analysis by the Acute Leukemia Working Party of the EBMT (2015) (42)
- Transplant Outcomes for Secondary Acute Myeloid Leukemia: Acute Leukemia Working Party of the European Society for Blood and Bone Marrow Transplantation Study. (2018) (42)
- Allogeneic hematopoietic stem cell transplantation for neuromyelitis optica (2014) (41)
- Allogeneic HSCT for Autoimmune Diseases: A Retrospective Study From the EBMT ADWP, IEWP, and PDWP Working Parties (2019) (41)
- Post-transplant cyclophosphamide after matched sibling, unrelated and haploidentical donor transplants in patients with acute myeloid leukemia: a comparative study of the ALWP EBMT (2020) (41)
- Genomic loss of mismatched human leukocyte antigen and leukemia immune escape from haploidentical graft-versus-leukemia. (2012) (41)
- IL-7 receptor expression identifies suicide gene-modified allospecific CD8+ T cells capable of self-renewal and differentiation into antileukemia effectors. (2011) (41)
- Unmanipulated haploidentical in comparison with matched unrelated donor stem cell transplantation in patients 60 years and older with acute myeloid leukemia: a comparative study on behalf of the ALWP of the EBMT (2018) (41)
- Identification, prevention and management of cardiovascular risk in chronic myeloid leukaemia patients candidate to ponatinib: an expert opinion (2017) (40)
- Gastrointestinal mucosal damage in patients with COVID-19 undergoing endoscopy: an international multicentre study (2021) (40)
- Long-term consequences of COVID-19 on cognitive functioning up to 6 months after discharge: role of depression and impact on quality of life (2021) (40)
- The spread of COVID-19 in six western metropolitan regions: a false myth on the excess of mortality in Lombardy and the defense of the city of Milan (2020) (40)
- Posttransplantation cyclophosphamide and sirolimus for prevention of GVHD after HLA-matched PBSC transplantation. (2016) (40)
- Peripheral blood stem cell graft compared to bone marrow after reduced intensity conditioning regimens for acute leukemia: a report from the ALWP of the EBMT (2016) (39)
- Label-free imaging and identification of typical cells of acute myeloid leukaemia and myelodysplastic syndrome by Raman microspectroscopy. (2015) (39)
- Genomic loss of patient-specific HLA in acute myeloid leukemia relapse after well-matched unrelated donor HSCT. (2012) (39)
- MATILDE chemotherapy regimen for primary CNS lymphoma (2014) (39)
- One-year mental health outcomes in a cohort of COVID-19 survivors (2021) (39)
- Killer cell immunoglobulin-like receptor ligand mismatching and outcome after haploidentical transplantation with post-transplant cyclophosphamide (2018) (38)
- Ropeginterferon alfa-2b versus phlebotomy in low-risk patients with polycythaemia vera (Low-PV study): a multicentre, randomised phase 2 trial. (2021) (38)
- Lentiviral haematopoietic stem-cell gene therapy for early-onset metachromatic leukodystrophy: long-term results from a non-randomised, open-label, phase 1/2 trial and expanded access (2022) (38)
- Blood neurofilament light chain and total tau levels at admission predict death in COVID-19 patients (2021) (38)
- Pretransplantation [18‐F]fluorodeoxyglucose positron emission tomography scan predicts outcome in patients with recurrent Hodgkin lymphoma or aggressive non‐Hodgkin lymphoma undergoing reduced‐intensity conditioning followed by allogeneic stem cell transplantation (2010) (37)
- High rate of hematological responses to sorafenib in FLT3‐ITD acute myeloid leukemia relapsed after allogeneic hematopoietic stem cell transplantation (2016) (37)
- The risk of COVID-19 death is much greater and age dependent with type I IFN autoantibodies (2022) (37)
- Alternative donors hematopoietic stem cells transplantation for adults with acute myeloid leukemia: Umbilical cord blood or haploidentical donors? (2010) (37)
- The impact of HLA matching on outcomes of unmanipulated haploidentical HSCT is modulated by GVHD prophylaxis. (2017) (37)
- Role of 18FDG-PET/CT in detecting relapse during follow-up of patients with Hodgkin’s lymphoma (2009) (37)
- Family Mismatched Allogeneic Stem Cell Transplantation for Myelofibrosis: Report from the Chronic Malignancies Working Party of European Society for Blood and Marrow Transplantation. (2019) (37)
- R-CHOP preceded by blood-brain barrier permeabilization with engineered tumor necrosis factor-α in primary CNS lymphoma. (2019) (36)
- Hematopoietic Stem- and Progenitor-Cell Gene Therapy for Hurler Syndrome. (2021) (36)
- Phase 1 Cohort Expansion of Flotetuzumab, a CD123×CD3 Bispecific Dart® Protein in Patients with Relapsed/Refractory Acute Myeloid Leukemia (AML) (2018) (36)
- Increase of circulating memory B cells after glucocorticoid-induced remission identifies patients at risk of IgG4-related disease relapse (2018) (36)
- S876 GILTERITINIB SIGNIFICANTLY PROLONGS OVERALL SURVIVAL IN PATIENTS WITH FLT3-MUTATED (FLT3MUT+) RELAPSED/REFRACTORY (R/R) ACUTE MYELOID LEUKEMIA (AML): RESULTS FROM THE PHASE 3 ADMIRAL TRIAL (2019) (36)
- Comparable outcomes of haploidentical, 10/10 and 9/10 unrelated donor transplantation in adverse karyotype AML in first complete remission (2018) (36)
- Unpredictability of intravenous busulfan pharmacokinetics in children undergoing hematopoietic stem cell transplantation for advanced beta thalassemia: limited toxicity with a dose-adjustment policy. (2010) (36)
- Th22 cells increase in poor prognosis multiple myeloma and promote tumor cell growth and survival (2015) (35)
- Pulmonary Vascular Thrombosis in COVID-19 Pneumonia (2021) (35)
- CD 44 v 6-targeted T cells mediate potent antitumor effects against acute myeloid leukemia and multiple myeloma (2013) (35)
- Multifocal laminar cortical brain lesions: a consistent MRI finding in neuro-COVID-19 patients (2020) (35)
- The CIBMTR score predicts survival of AML patients undergoing allogeneic transplantation with active disease after a myeloablative or reduced intensity conditioning: a retrospective analysis of the Gruppo Italiano Trapianto Di Midollo Osseo (2013) (35)
- IL-10-Engineered Human CD4+ Tr1 Cells Eliminate Myeloid Leukemia in an HLA Class I-Dependent Mechanism (2017) (34)
- Chronic GVHD is associated with inferior relapse risk irrespective of stem cell source among patients receiving transplantation from unrelated donors (2012) (34)
- Viral clearance after early corticosteroid treatment in patients with moderate or severe covid-19 (2020) (34)
- Bone marrow stromal cells from β-thalassemia patients have impaired hematopoietic supportive capacity (2019) (34)
- ATRA and Arsenic Trioxide (ATO) Versus ATRA and Idarubicin (AIDA) for Newly Diagnosed, Non High-Risk Acute Promyelocytic Leukemia (APL): Results of the Phase III, Prospective, Randomized, Intergroup APL0406 Study by the Italian-German Cooperative Groups Gimema-SAL-AMLSG (2012) (34)
- Clinical Impact of Pretransplant Multidrug-Resistant Gram-Negative Colonization in Autologous and Allogeneic Hematopoietic Stem Cell Transplantation. (2018) (34)
- Decreased in-hospital mortality in patients with COVID-19 pneumonia (2020) (33)
- Impact of ABO incompatibility on patients’ outcome after haploidentical hematopoietic stem cell transplantation for acute myeloid leukemia - a report from the Acute Leukemia Working Party of the EBMT (2017) (33)
- Early Treatment Intensification in Advanced-Stage High-Risk Hodgkin Lymphoma (HL) Patients, with a Positive FDG-PET Scan After Two ABVD Courses – First Interim Analysis of the GITIL/FIL HD0607 Clinical Trial (2012) (32)
- Results of a lymphoblastic leukemia-like chemotherapy program with risk-adapted mediastinal irradiation and stem cell transplantation for adult patients with lymphoblastic lymphoma (2011) (32)
- Expanding transplant options to patients over 50 years. Improved outcome after reduced intensity conditioning mismatched-unrelated donor transplantation for patients with acute myeloid leukemia: a report from the Acute Leukemia Working Party of the EBMT (2016) (32)
- Stranger Months: How SARS-CoV-2, Fear of Contagion, and Lockdown Measures Impacted Attendance and Clinical Activity During February and March 2020 at an Urban Emergency Department in Milan (2020) (32)
- ST-Segment–Elevation Myocardial Infarction During COVID-19 Pandemic (2020) (32)
- Enteric Microbiome Markers as Early Predictors of Clinical Outcome in Allogeneic Hematopoietic Stem Cell Transplant: Results of a Prospective Study in Adult Patients (2017) (32)
- Comparing transplant outcomes in ALL patients after haploidentical with PTCy or matched unrelated donor transplantation. (2020) (32)
- Management of patients with acute leukemia during the COVID-19 outbreak: practical guidelines from the acute leukemia working party of the European Society for Blood and Marrow Transplantation (2020) (31)
- Infections after allogenic transplant with post-transplant cyclophosphamide: impact of donor HLA-matching. (2020) (31)
- Autologous Bone Marrow Transplantation for the Treatment of Multiple Sclerosis (2014) (31)
- COVID-19 mortality rate in nine high-income metropolitan regions (2020) (31)
- Chest CT–derived pulmonary artery enlargement at the admission predicts overall survival in COVID-19 patients: insight from 1461 consecutive patients in Italy (2020) (31)
- Robust neutralizing antibodies to SARS-CoV-2 develop and persist in subjects with diabetes and COVID-19 pneumonia. (2021) (31)
- Unconventional CD147‐dependent platelet activation elicited by SARS‐CoV‐2 in COVID‐19 (2021) (31)
- Long‐term outcome after a treosulfan‐based conditioning regimen for patients with acute myeloid leukemia: A report from the Acute Leukemia Working Party of the European Society for Blood and Marrow Transplantation (2017) (31)
- Mechanisms of Leukemia Immune Evasion and Their Role in Relapse After Haploidentical Hematopoietic Cell Transplantation (2020) (31)
- Modeling multiple myeloma-bone marrow interactions and response to drugs in a 3D surrogate microenvironment (2018) (31)
- Testosterone in males with COVID‐19: A 7‐month cohort study (2021) (31)
- Related donor transplants: has posttransplantation cyclophosphamide nullified the detrimental effect of HLA mismatch? (2018) (30)
- RAAs inhibitors and outcome in patients with SARS-CoV-2 pneumonia. A case series study. (2020) (30)
- Angiotensin II infusion in COVID-19-associated vasodilatory shock: a case series (2020) (30)
- Tracking Genetically Engineered Lymphocytes Long-Term Reveals the Dynamics of T-Cell Immunological Memory (2015) (30)
- Conditioning intensity in secondary AML with prior myelodysplastic syndrome/myeloproliferative disorders: an EBMT ALWP study. (2018) (30)
- Post-transplant cyclophosphamide versus antithymocyte globulin in patients with acute myeloid leukemia in first complete remission undergoing allogeneic stem cell transplantation from 10/10 HLA-matched unrelated donors (2020) (30)
- Donor selection for a second allogeneic stem cell transplantation in AML patients relapsing after a first transplant: a study of the Acute Leukemia Working Party of EBMT (2019) (29)
- Impact of antithymocyte globulin doses in reduced intensity conditioning before allogeneic transplantation from matched sibling donor for patients with acute myeloid leukemia: a report from the acute leukemia working party of European group of Bone Marrow Transplantation (2018) (29)
- MYD88 L265P mutation and interleukin‐10 detection in cerebrospinal fluid are highly specific discriminating markers in patients with primary central nervous system lymphoma: results from a prospective study (2021) (29)
- Risk-associations between HLA-DPB1 T cell epitope matching and outcome of unrelated hematopoietic cell transplantation are independent from HLA-DPA1 (2014) (29)
- Assessment and prevention of cytomegalovirus infection in allogeneic hematopoietic stem cell transplant and in solid organ transplant: A multidisciplinary consensus conference by the Italian GITMO, SITO, and AMCLI societies (2019) (29)
- Control of infectious mortality due to carbapenemase-producing Klebsiella pneumoniae in hematopoietic stem cell transplantation (2017) (29)
- Plerixafor and G-CSF combination mobilizes hematopoietic stem and progenitors cells with a distinct transcriptional profile and a reduced in vivo homing capacity compared to plerixafor alone (2017) (28)
- RIC versus MAC UCBT in adults with AML: A report from Eurocord, the ALWP and the CTIWP of the EBMT (2016) (28)
- T-cell-replete haploidentical transplantation versus autologous stem cell transplantation in adult acute leukemia: a matched pair analysis (2015) (28)
- Biobanking for COVID-19 research. (2020) (28)
- Measurable residual disease (MRD) testing for acute leukemia in EBMT transplant centers: a survey on behalf of the ALWP of the EBMT (2020) (28)
- Effects of glucocorticoids on B-cell subpopulations in patients with IgG4-related disease. (2019) (27)
- Plerixafor on demand in ten healthy family donors as a rescue strategy to achieve an adequate graft for stem cell transplantation (2015) (27)
- Author Correction: Complement as a target in COVID-19? (2020) (27)
- Role of Rituximab and Rituximab Biosimilars in Diffuse Large B-Cell Lymphoma. (2016) (27)
- Respiratory Impairment Predicts Response to IL-1 and IL-6 Blockade in COVID-19 Patients With Severe Pneumonia and Hyper-Inflammation (2021) (27)
- Human Herpesvirus 6 Infection Following Haploidentical Transplantation: Immune Recovery and Outcome. (2016) (27)
- Experts’ considerations on HLA‐haploidentical stem cell transplantation (2014) (27)
- Lymphocytes genetically modified to express tumor antigens target DCs in vivo and induce antitumor immunity. (2007) (27)
- Clofarabine‐containing conditioning regimen for allo‐SCT in AML/ALL patients: a survey from the Acute Leukemia Working Party of EBMT (2012) (27)
- Wilms' tumor gene 1 transcript levels in leukapheresis of peripheral blood hematopoietic cells predict relapse risk in patients autografted for acute myeloid leukemia. (2014) (27)
- Genetically modified donor leukocyte transfusion and graft-versus-leukemia effect after allogeneic stem cell transplantation. (2011) (27)
- Prediction of Hematopoietic Stem Cell Transplantation Related Mortality- Lessons Learned from the In-Silico Approach: A European Society for Blood and Marrow Transplantation Acute Leukemia Working Party Data Mining Study (2016) (26)
- Unmanipulated haploidentical versus HLA-matched sibling allogeneic hematopoietic stem cell transplantation in relapsed/refractory acute myeloid leukemia: a retrospective study on behalf of the ALWP of the EBMT (2019) (26)
- HLA-G Expression on Blasts and Tolerogenic Cells in Patients Affected by Acute Myeloid Leukemia (2014) (26)
- Evaluation of Trends and Prognosis Over Time in Patients with AML Relapsing After Allogeneic Hematopoietic Cell Transplant Reveals Improved Survival for Young Patients in Recent Years (2020) (26)
- A new tool for rapid and reliable diagnosis of HLA loss relapses after HSCT. (2017) (26)
- Can Cytokine Blocking Prevent Depression in COVID-19 Survivors? (2020) (26)
- CAR T cell manufacturing from naive/stem memory T lymphocytes enhances antitumor responses while curtailing cytokine release syndrome (2022) (25)
- Minimal residual disease status predicts outcome of acute myeloid leukaemia patients undergoing T‐cell replete haploidentical transplantation. An analysis from the Acute Leukaemia Working Party (ALWP) of the European Society for Blood and Marrow Transplantation (EBMT) (2018) (25)
- Disrupting N-glycan expression on tumor cells boosts chimeric antigen receptor T cell efficacy against solid malignancies (2022) (25)
- Pre-transplant 18FDG-PET predicts outcome in lymphoma patients treated with high-dose sequential chemotherapy followed by autologous stem cell transplantation (2008) (25)
- Platelet transfusion refractoriness in highly immunized beta thalassemia children undergoing stem cell transplantation (2010) (25)
- Very low rate of readmission after an early discharge outpatient model for autografting in multiple myeloma patients: an Italian multicenter retrospective study. (2014) (25)
- Predicting failure of hematopoietic stem cell mobilization before it starts: the predicted poor mobilizer (pPM) score (2018) (24)
- Outcome of Allogeneic Hematopoietic Stem Cell Transplantation in Adult Patients with Philadelphia Positive Acute Lymphoblastic Leukemia in the Era of Tyrosine Kinase Inhibitors. A Registry-Based Study of the Italian Blood and Marrow Transplantation Society (Gitmo). (2019) (24)
- Correction: The European Society for Blood and Marrow Transplantation (EBMT) Consensus Guidelines for the Detection and Treatment of Donor-specific Anti-HLA Antibodies (DSA) in Haploidentical Hematopoietic Cell Transplantation (2018) (24)
- HLA-Mismatched Donors in Patients with Myelodysplastic Syndrome: An EBMT Registry Analysis. (2019) (24)
- Polymer nanopillar-gold arrays as surface-enhanced Raman spectroscopy substrate for the simultaneous detection of multiple genes. (2014) (24)
- Post-transplant cyclophosphamide versus anti-thymocyte globulin for graft-versus-host disease prevention in haploidentical transplantation for adult acute lymphoblastic leukemia (2020) (24)
- CXCL10 levels at hospital admission predict COVID-19 outcome: hierarchical assessment of 53 putative inflammatory biomarkers in an observational study (2021) (24)
- A dual role for genetically modified lymphocytes in cancer immunotherapy. (2012) (24)
- Long-term Clinical Outcomes of Hematopoietic Stem Cell Transplantation in Multiple Sclerosis (2021) (23)
- Haploidentical transplantation outcomes for secondary acute myeloid leukemia: Acute Leukemia Working Party (ALWP) of the European Society for Blood and Marrow Transplantation (EBMT) study (2018) (23)
- Updated risk-oriented strategy for acute lymphoblastic leukemia in adult patients 18–65 years: NILG ALL 10/07 (2020) (23)
- Final Results of Northern Italy Leukemia Group (NILG) Trial 10/07 Combining Pediatric-Type Therapy with Minimal Residual Disease Study and Risk-Oriented Hematopoietic Cell Transplantation in Adult Acute Lymphoblastic Leukemia (ALL) (2016) (23)
- Islet Allotransplantation in the Bone Marrow of Patients With Type 1 Diabetes: A Pilot Randomized Trial (2019) (23)
- Mutations of TP53 gene in adult acute lymphoblastic leukemia at diagnosis do not affect the achievement of hematologic response but correlate with early relapse and very poor survival (2016) (23)
- Angiopoietin-2 in Bone Marrow milieu promotes Multiple Myeloma-associated angiogenesis. (2015) (22)
- Abstract CT184: Gilteritinib significantly prolongs overall survival in patients withFLT3-mutated (FLT3mut+) relapsed/refractory (R/R) acute myeloid leukemia (AML): Results from the Phase III ADMIRAL trial (2019) (22)
- CD20 expression has no prognostic role in Philadelphia-negative B-precursor acute lymphoblastic leukemia: new insights from the molecular study of minimal residual disease (2012) (22)
- Therapeutic and diagnostic applications of minor histocompatibility antigen HA-1 and HA-2 disparities in allogeneic hematopoietic stem cell transplantation: a survey of different populations. (2006) (22)
- Escalating doses of donor lymphocytes for incipient graft rejection following SCT for thalassemia (2010) (22)
- A Phase III Study of Enoxaparin Versus Low-Dose Warfarin Versus Aspirin as Thromboprophylaxis for Patients with Newly Diagnosed Multiple Myeloma Treated up-Front with Thalidomide-Containing Regimens (2008) (22)
- Trends in the use of hematopoietic stem cell transplantation for adults with acute lymphoblastic leukemia in Europe: a report from the Acute Leukemia Working Party of the European Society for Blood and Marrow Transplantation (EBMT) (2019) (22)
- Circulating MicroRNAs as Potential Predictors of Anthracycline-Induced Troponin Elevation in Breast Cancer Patients: Diverging Effects of Doxorubicin and Epirubicin (2020) (22)
- Allogeneic hematopoietic cell transplantation from unrelated donors in multiple myeloma: study from the Italian Bone Marrow Donor Registry. (2013) (21)
- SETD2 and histone H3 lysine 36 methylation deficiency in advanced systemic mastocytosis (2017) (21)
- Hematopoietic stem cell transplantation with unrelated cord blood or haploidentical donor grafts in adult patients with secondary acute myeloid leukemia, a comparative study from Eurocord and the ALWP EBMT (2019) (21)
- Comparable survival using a CMV-matched or a mismatched donor for CMV+ patients undergoing T-replete haplo-HSCT with PT-Cy for acute leukemia: a study of behalf of the infectious diseases and acute leukemia working parties of the EBMT (2018) (21)
- Bone Marrow and Pancreatic Islets: An Old Story with New Perspectives (2010) (21)
- CD4+ Memory Stem T Cells Recognizing Citrullinated Epitopes Are Expanded in Patients With Rheumatoid Arthritis and Sensitive to Tumor Necrosis Factor Blockade (2020) (21)
- Post-transplantation cyclophosphamide GvHD prophylaxis after hematopoietic stem cell transplantation from 9/10 or 10/10 HLA-matched unrelated donors for acute leukemia (2020) (21)
- Pioglitazone as a novel therapeutic approach in chronic granulomatous disease (2016) (21)
- T‐cell replete haploidentical stem cell transplantation attenuates the prognostic impact of FLT3‐ITD in acute myeloid leukemia: A report from the Acute Leukemia Working Party of the European Society for Blood and Marrow Transplantation (2018) (21)
- Graft-versus-leukemia effect of HLA-haploidentical central-memory T-cells expanded with leukemic APCs and modified with a suicide gene. (2013) (21)
- Bendamustine combined with donor lymphocytes infusion in Hodgkin's lymphoma relapsing after allogeneic hematopoietic stem cell transplantation. (2014) (21)
- Clinical and immunologic responses in melanoma patients vaccinated with MAGE‐A3‐genetically modified lymphocytes (2013) (20)
- Factors predicting outcome after allogeneic transplant in refractory acute myeloid leukemia: a retrospective analysis of Gruppo Italiano Trapianto di Midollo Osseo (GITMO) (2017) (20)
- Chromogranin A Is Preferentially Cleaved into Proangiogenic Peptides in the Bone Marrow of Multiple Myeloma Patients. (2016) (20)
- Comparison of Haploidentical Bone Marrow versus Matched Unrelated Donor Peripheral Blood Stem Cell Transplantation with Posttransplant Cyclophosphamide in Patients with Acute Leukemia (2020) (20)
- Genotypes and haplotypes in the 3' untranslated region of the HLA-G gene and their association with clinical outcome of hematopoietic stem cell transplantation for beta-thalassemia. (2012) (20)
- Randomized trial comparing standard vs sequential high-dose chemotherapy for inducing early CR in adult AML. (2019) (20)
- Allogeneic stem cell transplantation for the treatment of advanced solid tumors (2004) (20)
- Interleukin-6 as Biomarker for Acute GvHD and Survival After Allogeneic Transplant With Post-transplant Cyclophosphamide (2019) (20)
- Autologous Pancreatic Islet Transplantation in Human Bone Marrow. Diabetes 2013;62:3523–3531 (2013) (19)
- CD3+ graft cell count influence on chronic GVHD in haploidentical allogeneic transplantation using post-transplant cyclophosphamide (2018) (19)
- Cellular and transcriptional dynamics of human neutrophils at steady state and upon stress (2022) (19)
- Positive HCMV DNAemia in stem cell recipients undergoing letermovir prophylaxis is expression of abortive infection (2020) (19)
- Haploidentical transplant in patients with myelodysplastic syndrome. (2017) (19)
- Inflammation converts human mesoangioblasts into targets of alloreactive immune responses: implications for allogeneic cell therapy of DMD. (2014) (19)
- Physical and psychological sequelae at three months after acute illness in COVID-19 survivors. (2021) (19)
- Transplant-Associated Thrombotic Microangiopathy (TA-TMA) and Consensus Based Diagnostic and Therapeutic Recommendations: Which TA-TMA Patients to Treat and When? (2014) (18)
- Long-Term Follow-up of Patients Affected by Relapsed Lymphomas Receiving Reduced-Intensity Conditioning (RIC) Regimen Followed by Allogeneic Stem Cell Transplantation (Allo-SCT): An Update of the Phase II Study of the Gruppo Italiano Trapianto Di Midollo Osseo (GITMO) (2008) (18)
- Post‐transplantation cyclophosphamide versus antithymocyte globulin in patients with acute myeloid leukemia undergoing allogeneic stem cell transplantation from HLA‐identical sibling donors: A retrospective analysis from the Acute Leukemia Working Party of the European Society for Blood and Marrow T (2020) (18)
- Improving the antitumor activity of R-CHOP with NGR-hTNF in primary CNS lymphoma: final results of a phase 2 trial. (2020) (18)
- Suicide Gene Transduced T‐cells for the Regulation of the Graft‐versus‐Leukemia Effect (1998) (18)
- Isolated bone marrow occurrence of classic Hodgkin's lymphoma in an HIV-negative patient. (2006) (18)
- Autologous stem cell transplantation is still a valid option in good- and intermediate-risk AML: a GITMO survey on 809 patients autografted in first complete remission (2017) (18)
- Outcomes of Unrelated Cord Blood and Haploidentical Stem Cell Transplantation in Adults with Acute Leukaemia. (2005) (18)
- Long-term results and GvHD after prophylactic and preemptive donor lymphocyte infusion after allogeneic stem cell transplantation for acute leukemia (2021) (18)
- Timing of Post-Transplantation Cyclophosphamide Administration in Haploidentical Transplantation: A Comparative Study on Behalf of the Acute Leukemia Working Party of the European Society for Blood and Marrow Transplantation (2020) (17)
- The risk of COVID-19 death is much greater and age-dependent with type I IFN autoantibodies (2022) (17)
- Post-transplant cyclophosphamide containing regimens after matched sibling, matched unrelated and haploidentical donor transplants in patients with acute lymphoblastic leukemia in first complete remission, a comparative study of the ALWP of the EBMT (2021) (17)
- Incidence of deep venous thrombosis in COVID-19 hospitalized patients during the first peak of the Italian outbreak (2020) (17)
- Treatment approaches for primary CNS lymphomas (2010) (17)
- Treatment of steroid resistant acute graft versus host disease with an anti-CD26 monoclonal antibody—Begelomab (2020) (17)
- COVID-19 Vaccination in Fragile Patients: Current Evidence and an Harmonized Transdisease Trial (2021) (16)
- Choosing the Alternative. (2017) (16)
- Post-Transplant Cyclophosphamide and Sirolimus based Graft-versus-Host-Disease Prophylaxis in Allogeneic Stem Cell Transplant. (2021) (16)
- Subclinical myocardial dysfunction in patients recovered from COVID‐19 (2021) (16)
- First Occurrence of Plasmablastic Lymphoma in Adenosine Deaminase-Deficient Severe Combined Immunodeficiency Disease Patient and Review of the Literature (2018) (16)
- Bone marrow as a source of hematopoietic stem cells for human gene therapy of β-thalassemia. (2011) (16)
- Incidence of HLA Loss in a Global Multicentric Cohort of Post-Transplantation Relapses: Results from the Hlaloss Collaborative Study (2018) (16)
- Natural killer cell alloreactivity in HLA-haploidentical hematopoietic transplantation: a study on behalf of the CTIWP of the EBMT (2021) (16)
- No Evidence of Long-Term Disruption of Glycometabolic Control After SARS-CoV-2 Infection (2021) (15)
- Circulating cytochrome c as potential biomarker of impaired reperfusion in ST-segment elevation acute myocardial infarction. (2010) (15)
- Outcome of patients activating an unrelated donor search: the impact of transplant with reduced intensity conditioning in a large cohort of consecutive high-risk patients (2012) (15)
- Progress and prospects: graft-versus-host disease (2010) (15)
- A novel genomic inversion in Wiskott-Aldrich–associated autoinflammation (2016) (15)
- Gene Therapy for Beta Thalassemia: Preliminary Results from the PHASE I/II Tiget-Bthal Trial of Autologous Hematopoietic Stem Cells Genetically Modified with GLOBE Lentiviral Vector (2017) (15)
- Impact of conditioning intensity on outcomes of haploidentical stem cell transplantation for patients with acute myeloid leukemia 45 years of age and over (2019) (15)
- Innovative Platforms for Haploidentical Stem Cell Transplantation: The Role of Unmanipulated Donor Graft (2011) (15)
- Epicardial adipose tissue characteristics, obesity and clinical outcomes in COVID-19: A post-hoc analysis of a prospective cohort study (2021) (14)
- Development and validation of a disease risk stratification system for patients with haematological malignancies: a retrospective cohort study of the European Society for Blood and Marrow Transplantation registry. (2021) (14)
- Genomic typing for patient-specific human leukocyte antigen-alleles is an efficient tool for relapse detection of high-risk hematopoietic malignancies after stem cell transplantation from alternative donors (2008) (14)
- Primary sternal osteomyelitis by Aspergillus fumigatus. (1994) (14)
- Following-up allogeneic transplantation recipients during the COVID-19 pandemic (2020) (14)
- MicroCLOTS pathophysiology in COVID 19. (2020) (14)
- ABO incompatibility in mismatched unrelated donor allogeneic hematopoietic cell transplantation for acute myeloid leukemia: A report from the acute leukemia working party of the EBMT (2017) (14)
- Long-term follow-up of metastatic renal cancer patients undergoing reduced-intensity allografting (2009) (14)
- Phase I-IIa Clinical Trial to Assess Safety and Efficacy of MLM-CAR44.1, a CD44v6 Directed CAR-T in Relapsed/Refractory Acute Myeloid Leukemia (AML) and Multiple Myeloma (MM) (2018) (14)
- Renin-Angiotensin-Aldosterone System Inhibitors and Outcome in Patients With SARS-CoV-2 Pneumonia (2020) (14)
- COVID-19: Pharmacology and kinetics of viral clearance (2020) (14)
- Cervical thymic hyperplasia after chemotherapy in an adult patient with Hodgkin lymphoma: a potential cause of false‐positivity on [18F]FDG PET/CT scanning (2008) (13)
- Event Diagnosis and Recovery in Real-Time On-Board Autonomous Mission Control (1994) (13)
- Post-Transplant Cyclophosphamide after Matched Sibling, Unrelated and Haploidentical Donor Transplants in Patients with Acute Myeloid Leukemia, a Comparative Study of the ALWP EBMT (2019) (13)
- Interleukin-10 Anergized Donor T Cell Infusion Improves Immune Reconstitution without Severe Graft-Versus-Host-Disease After Haploidentical Hematopoietic Stem Cell Transplantation. (2009) (13)
- Microbiome Markers are Early Predictors of Acute GvHD in Allogeneic Hematopoietic Stem Cell Transplant recipients. (2020) (13)
- Long term follow up of patients after allogeneic stem cell transplantation and transfusion of HSV-TK transduced T-cells (2015) (13)
- Application of donor lymphocytes expressing a suicide gene for early GVL induction and later control of GVH reactions after bone-marrow transplantation. (2005) (12)
- Flotetuzumab, an Investigational CD123 x CD3 Bispecific Dart® Protein, in Salvage Therapy for Primary Refractory and Early Relapsed Acute Myeloid Leukemia (AML) Patients (2019) (12)
- Abnormalities of acid-base balance and predisposition to metabolic acidosis in Metachromatic Leukodystrophy patients. (2015) (11)
- Leukemia relapse following unmanipulated haploidentical transplantation: a risk factor analysis on behalf of the ALWP of the EBMT (2019) (11)
- Early recovery of CMV immunity after HLA-haploidentical hematopoietic stem cell transplantation as a surrogate biomarker for a reduced risk of severe infections overall (2015) (11)
- Bone marrow-derived CD34- fraction: A rich source of mesenchymal stromal cells for clinical application. (2016) (11)
- Missing HLA C group 1 ligand in patients with AML and MDS is associated with reduced risk of relapse and better survival after allogeneic stem cell transplantation with fludarabine and treosulfan reduced toxicity conditioning (2014) (11)
- Changes in Stem Cell Transplant activity and procedures during SARS-CoV2 pandemic in Italy: an Italian Bone Marrow Transplant Group (GITMO) nationwide analysis (TransCOVID-19 Survey) (2021) (11)
- Long‐lasting efficacy and safety of lenalidomide maintenance in patients with relapsed diffuse large B‐cell lymphoma who are not eligible for or failed autologous transplantation (2020) (11)
- Successful Treatment With Ledipasvir/Sofosbuvir in an Infant With Severe Combined Immunodeficiency Caused by Adenosine Deaminase Deficiency With HCV Allowed Gene Therapy with Strimvelis (2018) (11)
- Quantitative serological evaluation as a valuable tool in the COVID-19 vaccination campaign (2021) (11)
- Second allogeneic haematopoietic cell transplantation using HLA‐matched unrelated versus T‐cell replete haploidentical donor and survival in relapsed acute myeloid leukaemia (2021) (11)
- Circulating biomarkers and cardiac function over 3 years after chemotherapy with anthracyclines: the ICOS‐ONE trial (2020) (11)
- T cells for suicide gene therapy: activation, functionality and clinical relevance. (2008) (11)
- Multiparametric Whole Blood Dissection: A one‐shot comprehensive picture of the human hematopoietic system (2017) (11)
- Response to: ‘More evidences on which biologic and which pathway is key in severe-critical COVID-19 pneumonia’ by Ferraccioli (2020) (10)
- Monocyte-derived IL-1 and IL-6 are differentially required for cytokine-release syndrome and neurotoxicity due to CAR T cells (2018) (10)
- DYNAMIC SIMULATION OF MAN-MACHINE INTERACTION IN INCIDENT CONTROL (1985) (10)
- Beneficial role of CD8+ T-cell reconstitution after HLA-haploidentical stem cell transplantation for high-risk acute leukaemias: results from a clinico-biological EBMT registry study mostly in the T-cell-depleted setting (2018) (10)
- Efficacy, safety and long term results of prophylactic and preemptive donor lymphocyte infusion after allogeneic stem cell transplantation for acute leukemia: a registry-based evaluation on 343 patients by the acute leukemia working party of EBMT. (2015) (10)
- Management of Cytokine Release Syndrome in AML Patients Treated with Flotetuzumab, a CD123 x CD3 Bispecific Dart® Molecule for T-Cell Redirected Therapy (2018) (10)
- Thromboembolism risk among patients with diabetes/stress hyperglycemia and COVID-19 (2021) (10)
- Myocardial injury in patients with SARS‐CoV‐2 pneumonia: Pivotal role of inflammation in COVID‐19 (2021) (10)
- In patients older than 55 years with AML in first CR, should we search for a matched unrelated donor when an old sibling donor is available? (2015) (10)
- Humoral and T-cell immune response after three doses of mRNA SARS-CoV-2 vaccines in fragile patients: the Italian VAX4FRAIL study (2022) (10)
- Emapalumab treatment in an ADA-SCID patient with refractory hemophagocytic lymphohistiocytosis- related graft failure and disseminated bacillus Calmette-Guérin infection (2020) (10)
- Changes in T-cell responses against human herpesvirus-8 correlate with the disease course of iatrogenic Kaposi's sarcoma in a patient with undifferentiated arthritis. (2009) (10)
- Suicide-Gene-Transduced Donor T-Cells for Controlled Graft-versus-Host Disease and Graft-Versus-Tumor (2002) (9)
- Integrated Genomic, Functional, and Prognostic Characterization of Atypical Chronic Myeloid Leukemia (2020) (9)
- Clinical significance of chromatin-spliceosome acute myeloid leukemia: a report from the Northern Italy Leukemia Group (NILG) randomized trial 02/06 (2020) (9)
- Acute Myeloid Leukemia Relapses after Allogenenic HSCT Display a Distinctive Immune-Related Signature, with Frequent and Functionally Relevant Alterations in HLA Class II Antigen Presentation and T Cell Costimulation (2014) (9)
- Flotetuzumab As Salvage Therapy for Primary Induction Failure and Early Relapse Acute Myeloid Leukemia (2020) (9)
- Stem cell transplantation from a haploidentical donor versus a genoidentical sister for adult male patients with acute myelogenous leukemia in first remission: A retrospective study from the acute leukemia working party of the European Society for Blood and Marrow Transplantation (2019) (9)
- Lentiviral hematopoietic stem and progenitor cell gene therapy (HSPC-GT) for metachromatic leukodystrophy (MLD): Clinical outcomes from 33 patients (2020) (9)
- Multiple Inhibitory Receptors Are Expressed on Central Memory and Memory Stem T Cells Infiltrating the Bone Marrow of AML Patients Relapsing after Allo-HSCT (2016) (9)
- Comparing outcomes of a second allogeneic hematopoietic cell transplant using HLA-matched unrelated versus T-cell replete haploidentical donors in relapsed acute lymphoblastic leukemia: a study of the Acute Leukemia Working Party of EBMT (2021) (9)
- Use of Bone Marrow or Peripheral Blood Stem Cell Grafts in Non T Cell Depleted Haploidentical Transplants Using Post-Transplant Cyclophosphamide, an ALWP-EBMT Analysis (2016) (9)
- Integrated Multiomic Profiling Identifies the Epigenetic Regulator PRC2 as a Therapeutic Target to Counteract Leukemia Immune Escape and Relapse (2022) (9)
- Manipulation, and cryopreservation of autologous peripheral blood stem cell products in Italy: A survey by GITMO, SIDEM and GIIMA societies. (2020) (9)
- Cost-effectiveness analysis of the use of letermovir for the prophylaxis of cytomegalovirus in adult cytomegalovirus seropositive recipients undergoing allogenic hematopoietic stem cell transplantation in Italy (2019) (9)
- Long-Term Safety and Efficacy of Gene Therapyfor Adenosine Deaminase (ADA)-Deficient Severe Combined Immunodeficiency (2009) (9)
- Haploidentical related donor compared to HLA-identical donor transplantation for chemosensitive Hodgkin lymphoma patients (2020) (9)
- Fatal vancomycin- and linezolid-resistant Enterococcus faecium sepsis in a child undergoing allogeneic haematopoietic stem cell transplantation for beta-thalassaemia major. (2010) (9)
- A multicentre, multinational, prospective, observational registry study of defibrotide in patients diagnosed with veno-occlusive disease/sinusoidal obstruction syndrome after haematopoietic cell transplantation: an EBMT study (2021) (9)
- Use of Defibrotide to help prevent post-transplant endothelial injury in a genetically predisposed infant with metachromatic leukodystrophy undergoing hematopoietic stem cell gene therapy (2018) (9)
- T‐cell–depleted haploidentical stem cell transplantation results improve with time in adults with acute leukemia: A study from the Acute Leukemia Working Party of the European Society of Blood and Marrow Transplantation (EBMT) (2018) (8)
- Prolonged survival in the absence of disease-recurrence in advanced-stage follicular lymphoma following chemo-immunotherapy: 13-year update of the prospective, multicenter randomized GITMO-IIL trial (2019) (8)
- Improved Outcomes of Haploidentical Hematopoietic Cell Transplantation with Total Body Irradiation-Based Myeloablative Conditioning in Acute Lymphoblastic Leukemia. (2021) (8)
- A phase I, first-in-human study of MGD006/S80880 (CD123 x CD3 DART) in AML/MDS. (2017) (8)
- Impact of total body irradiation‐ vs chemotherapy‐based myeloablative conditioning on outcomes of haploidentical hematopoietic cell transplantation for acute myelogenous leukemia (2020) (8)
- CRISPR-based gene disruption and integration of high-avidity, WT1-specific T cell receptors improve antitumor T cell function (2022) (8)
- Graft-Versus-Host Disease Prophylaxis with Post-Transplantation Cyclophosphamide versus Cyclosporine A and Methotrexate in Matched Sibling Donor Transplantation (2021) (8)
- The impact of histopathologic examination of graft-versus-host disease in the era of reduced-intensity conditioning regimen: a study from the Gruppo Italiano Trapianto di Midollo Osseo. (2011) (8)
- Immunomodulatory Drugs in the Context of Autologous Hematopoietic Stem Cell Transplantation Associate With Reduced Pro-tumor T Cell Subsets in Multiple Myeloma (2019) (8)
- Validation of the "fitness criteria" for the treatment of older patients with acute myeloid leukemia: A multicenter study on a series of 699 patients by the Network Rete Ematologica Lombarda (REL). (2020) (8)
- Ultrasound elastography techniques for diagnosis and follow-up of hepatic veno-occlusive disease (2019) (8)
- Chemotherapy dose adjustment for obese patients undergoing hematopoietic stem cell transplantation: a survey on behalf of the Acute Leukemia Working Party of the European Society for Blood and Marrow Transplantation. (2015) (8)
- Outcomes of haploidentical stem cell transplantation for chronic lymphocytic leukemia: a retrospective study on behalf of the chronic malignancies working party of the EBMT (2018) (8)
- Tracking T Cell Dynamics In The First Month After Haplo-HSCT With Post-Transplant Cyclophosphamide Reveals a Predominant Contribution Of Memory Stem T Cells To The Early Phase Of Immune Reconstitution (2013) (8)
- Post-transplant cyclophosphamide in one-antigen mismatched unrelated donor transplantation versus haploidentical transplantation in acute myeloid leukemia: a study from the Acute Leukemia Working Party of the EBMT (2022) (8)
- Treosulfan conditioning for allogeneic transplantation in multiple myeloma – improved overall survival in first line haematopoietic stem cell transplantation – a large retrospective study by the Chronic Malignancies Working Party of the EBMT (2020) (8)
- Cost-effectiveness of blood culture and a multiplex real-time PCR in hematological patients with suspected sepsis: an observational propensity score-matched study (2014) (8)
- A phase II/III, multicenter, open-label, 3-arm study of gilteritinib, gilteritinib plus azacitidine, or azacitidine alone in the treatment of newly diagnosed FLT3 mutation-positive acute myeloid leukemia (AML) patients ineligible for intensive induction chemotherapy. (2017) (7)
- GITMO REGISTRY STUDY ON ALLOGENEIC TRANSPLANTATION IN PATIENTS AGED OVER 60 FROM 2000 TO 2017. IMPROVEMENTS AND CRITICISMS (2021) (7)
- Peripherally Inserted Central Catheters (PICCs) Implantation in the Clinical Management of Oncohematologic Patients: Results of a Large Multicenter, Retrospective Study of the REL Group (Rete Ematologica Lombarda - Lombardy Hematologic Network, Italy) (2015) (7)
- Erratum: Sorafenib promotes graft-versus-leukemia activity in mice and humans through IL-15 production in FLT3-ITD-mutant leukemia cells (2018) (7)
- CD44v6 Is Required For In Vivo Tumorigenesis Of Human AML and MM Cells: Role Of Microenvironmental Signals and Therapeutic Implications (2013) (7)
- Role of blood pressure dysregulation on kidney and mortality outcomes in COVID-19. Kidney, blood pressure and mortality in SARS-CoV-2 infection (2021) (7)
- CMV Management with Specific Immunoglobulins: A Multicentric Retrospective Analysis on 92 Allotransplanted Patients (2019) (7)
- Allogeneic hematopoietic cell transplantation with cord blood versus mismatched unrelated donor with post-transplant cyclophosphamide in acute myeloid leukemia (2021) (7)
- Rapid and Wide Immunereconstitution Obtained with HSV-TK Engineered Donor Lymphocyte Add-Backs Permits Long-Term Survival after haplo-HSCT. (2006) (7)
- Adjuvant role of SeptiFast to improve the diagnosis of sepsis in a large cohort of hematological patients (2018) (7)
- Update of a GITIL Cohort Study: Frontline High Dose Sequential Chemotherapy with Rituximab and Autologous Stem Cell Transplantation Induces a High Rate of Long-Term Remissions in Patients with Mantle Cell Lymphoma (2007) (7)
- The timing of post-transplant cyclophosphamide administration in haploidentical transplantation: a comparative study on behalf of the ALWP of the EBMT. (2020) (7)
- Title : NY-ESO-1 TCR single edited central memory and memory stem T cells to treat multiple myeloma without inducing GvHD (2017) (7)
- Lead-in Dose Optimization to Mitigate Cytokine Release Syndrome in AML and MDS Patients Treated with Flotetuzumab, a CD123 x CD3 Dart® Molecule for T-Cell Redirected Therapy (2017) (6)
- Coadministration of posaconazole and sirolimus in allogeneic hematopoietic stem cell transplant recipients (2016) (6)
- Quality of Response in Acute Myeloid Leukemia: The Role of Minimal Residual Disease (2019) (6)
- A New Clinicobiological Scoring System for the Prediction of Infection-Related Mortality and Survival after Allogeneic Hematopoietic Stem Cell Transplantation. (2017) (6)
- Efficacy of a rational algorithm to assess allergy risk in patients receiving the BNT162b2 vaccine. (2021) (6)
- Erratum: Tracking genetically engineered lymphocytes long-term reveals the dynamics of T cell immunological memory (Science Translational Medicine (2015) 7:319 (319er9)) (2015) (6)
- How to get away with COVID-19: endoscopy during post-peak pandemic. A perspective review (2020) (6)
- Drug reaction with eosinophilia and systemic symptoms (DRESS) in patients with COVID-19 (2021) (6)
- Co-Expression of a Suicide Gene in CAR-Redirected T Cells Enables the Safe Targeting of CD44v6 for Leukemia and Myeloma Eradication (2012) (6)
- Multiple BM harvests in pediatric donors for thalassemic siblings: safety, efficacy and ethical issues (2008) (6)
- Bone marrow harvesting from paediatric patients undergoing haematopoietic stem cell gene therapy (2019) (6)
- Impact of HLA-G polymorphism on the outcome of allogeneic hematopoietic stem cell transplantation for metastatic renal cell carcinoma (2018) (6)
- Humoral and T-Cell Immune Response After 3 Doses of Messenger RNA Severe Acute Respiratory Syndrome Coronavirus 2 Vaccines in Fragile Patients: The Italian VAX4FRAIL Study (2022) (6)
- Humoral and T-Cell Immune Response After 3 Doses of Messenger RNA Severe Acute Respiratory Syndrome Coronavirus 2 Vaccines in Fragile Patients: The Italian VAX4FRAIL Study (2022) (6)
- Immune monitoring in allogeneic hematopoietic stem cell transplant recipients: a survey from the EBMT-CTIWP (2018) (6)
- Final Results of a Prospective Randomized Multicenter Phase III Trial Comparing Treosulfan/Fludarabine to Reduced Intensity Conditioning with Busulfan/Fludarabine Prior to Allogeneic Hematopoietic Stem Cell Transplantation in Elderly or Comorbid Patients with Acute Myeloid Leukemia or Myelodysplasti (2017) (6)
- Quantitative assessment of lung involvement on chest CT at admission: Impact on hypoxia and outcome in COVID-19 patients (2021) (6)
- Allogeneic Genetically Modified T Cells (HSV-TK) As Adjunctive Treatment in Haploidentical Hematopoietic Stem-Cell Transplantation (haplo-HSCT) of Adult Patients with High-Risk Hematological Malignancies: A Pair-Matched Analysis from the Acute Leukemia Working Party of EBMT (2016) (6)
- Safety and Clinical Benefit of Lentiviral Hematopoietic Stem Cell Gene Therapy for Wiskott-Aldrich Syndrome (2015) (6)
- BAT2 and BAT3 polymorphisms as novel genetic risk factors for rejection after HLA-related stem cell transplantation (2014) (5)
- Chromogranin A plasma levels predict mortality in COVID-19 (2022) (5)
- Treosulfan based reduced toxicity conditioning followed by allogeneic stem cell transplantation in patients with myelofibrosis (2016) (5)
- Integrating a prospective pilot trial and patient-derived xenografts to trace metabolic changes associated with acute myeloid leukemia (2016) (5)
- Haploidentical transplant with post-transplant cyclophosphamide for T-cell acute lymphoblastic leukemia: a report from the EBMT acute leukemia working party. (2020) (5)
- Long-term follow-up of metastatic renal cancer patients undergoing reduced-intensity allografting. (2009) (5)
- Comparison of outcomes for HLA-matched sibling and haplo-identical donors in Myelodysplastic syndromes: report from the chronic malignancies working party of EBMT (2022) (5)
- Mood-congruent negative thinking styles and cognitive vulnerability in depressed COVID-19 survivors: A comparison with major depressive disorder (2022) (5)
- mRNA-COVID19 Vaccination Can Be Considered Safe and Tolerable for Frail Patients (2022) (5)
- Prolonged Survival Of Poor Risk Follicular Lymphoma Patients Following Primary Treatment With Rituximab-Supplemented CHOP Or HDS With Autograft: Long-Term Results Of The Multicenter Randomized GITMO/FIL Trial (2013) (5)
- Longitudinal qPCR monitoring of nucleophosmin 1 mutations after allogeneic hematopoietic stem cell transplantation to predict AML relapse (2016) (5)
- Allogeneic hematopoietic cell transplantation in patients with myelodysplastic syndrome using treosulfan based compared to other reduced‐intensity or myeloablative conditioning regimens. A report of the chronic malignancies working party of the EBMT (2021) (5)
- Incidence of human cytomegalovirus infection in patients with refractory solid tumors receiving nonmyeloablative allogeneic stem cell transplants versus recipients of standard SCT for hematologic malignancies. (2005) (5)
- Prophylactic Ruxolitinib for Cytokine Release Syndrome (CRS) in Relapse/Refractory (R/R) AML Patients Treated with Flotetuzumab (2020) (5)
- COVID-19 in recipients of allogeneic stem cell transplantation: favorable outcome (2021) (5)
- Nilotinib in steroid-refractory cGVHD: prospective parallel evaluation of response, according to NIH criteria and exploratory response criteria (GITMO criteria) (2020) (5)
- Comparative evaluation of biological human leukocyte antigen DPB1 mismatch models for survival and graft-versus-host disease prediction after unrelated donor hematopoietic cell transplantation (2020) (5)
- Donor Lymphocyte Infusions After Allogeneic Stem Cell Transplantation in Acute Leukemia: A Survey From the Gruppo Italiano Trapianto Midollo Osseo (GITMO) (2020) (5)
- Surface Enhanced Raman Spectroscopy-Based Method for Leukemia Biomarker Detection Using Magnetic Core @ Gold Shell Nanoparticles (2014) (5)
- Multifocal transient cortical brain lesions: a consistent MRI finding in neuro-COVID-19 patients (2020) (5)
- Haploidentical HSCT: a 15-year experience at San Raffaele (2015) (5)
- Genomic Loss of the Mismatched HLA Locus in Leukemia Is a Major Mechanism of in Vivo Escape from T Cell Immunosurveillance Following Haploidentical HSCT (2008) (5)
- Outcome of T‐cell–replete haploidentical stem cell transplantation improves with time in adults with acute lymphoblastic leukemia: A study from the Acute Leukemia Working Party of the European Society for Blood and Marrow Transplantation (2021) (5)
- QTc interval prolongation, inflammation, and mortality in patients with COVID-19 (2021) (5)
- Lentiviral Hematopoietic Stem and Progenitor Cell Gene Therapy for Wiskott-Aldrich Syndrome (WAS): Up to 8 Years of Follow up in 17 Subjects Treated Since 2010 (2019) (5)
- Neural stem cell transplantation in patients with progressive multiple sclerosis: an open-label, phase 1 study (2023) (5)
- The place in therapy of ceftazidime/avibactam and ceftolozane/tazobactam in hematological patients with febrile neutropenia. (2021) (5)
- Myeloablative conditioning with thiotepa-busulfan-fludarabine does not improve the outcome of patients transplanted with active leukemia: final results of the GITMO prospective trial GANDALF-01 (2022) (4)
- Treosulfan Based Conditioning Prior To Allogeneic Stem Cell Transplantation (HSCT) For Acute Myelogenous Leukemia (AML): A Retrospective Analysis From The ALWP Of The EBMT (2013) (4)
- Ruxolitinib for chronic steroid-refractory graft versus host disease: a single center experience. (2021) (4)
- Prediction of allogeneic hematopoietic stem cell transplantation (allo-HSCT) related mortality in acute leukemia: generation of a machine learning-based model using the data set of the acute leukemia working party (ALWP) of the EBMT (2013) (4)
- Prognostic Value of Positron Emission Tomography (PET) Scan in Patients with Relapsed Hodgkin Lymphoma or Aggressive Non-Hodgkin Lymphoma Receiving Salvage Chemotherapy Followed by Reduced-Intensity Allogeneic Stem Cell Transplantation. (2007) (4)
- Seasonal Betacoronavirus Antibodies’ Expansion Post-BNT161b2 Vaccination Associates with Reduced SARS-CoV-2 VoC Neutralization (2021) (4)
- High Throughput Molecular Characterization of Normal Karyotype Acute Myeloid Leukemia in the Context of the Prospective Trial 02/06 of the Northern Italy Leukemia Group (NILG) (2020) (4)
- Extensive Metabolic Correction of Hurler Disease By Hematopoietic Stem Cell-Based Gene Therapy: Preliminary Results from a Phase I/II Trial (2019) (4)
- Trend towards reduction in COVID-19 in-hospital mortality (2021) (4)
- COVID-19 and Stem Cell Transplantation; Results from the Prospective Survey By the Infectious Diseases Working Party of the European Society for Blood and Marrow Transplantation (EBMT) and the Spanish Hematopoietic Stem Cell Transplantation and Cell Therapy Group (GETH) (2020) (4)
- Non-Permissive HLA-DPB1 Disparity is a Significant Independent Risk Factor for Mortality after Unrelated Hematopoietic Stem Cell Transplantation Running Title: Nonpermissive HLA-DPB1 disparity in unrelated HSCT (2009) (4)
- Comparison of outcomes after unrelated double-unit cord blood and haploidentical peripheral blood stem cell transplantation in adults with acute myeloid leukemia, a study on behalf of Eurocord and ALWP-EBMT. (2022) (4)
- Underdiagnosed veno-occlusive disease/sinusoidal obstruction syndrome (VOD/SOS) as a major cause of multi-organ failure in acute leukemia transplant patients: an analysis from the EBMT Acute Leukemia Working Party (2020) (4)
- Pre-Existing Diabetes and COVID-Associated Hyperglycaemia in Patients with COVID-19 Pneumonia (2021) (4)
- Infusion of Donor Lymphocytes Genetically Engineered to Express the Herpes Simplex Virus Thymidine Kinase (HSV-TK) Suicide Gene after Haploidentical Hematopoietic Stem Cell Transplantation (HSCT): Preliminary Efficacy Data from the Randomized TK008 Study (2014) (4)
- Post-Transplant Cyclophosphamide for Graft vs Host Disease Prophylaxis in Multiple Myeloma Patients Who Underwent Allogeneic Hematopoietic Cell Transplantation: First Comparison by Donor Type: A Study from the Chronic Malignancies Working Party of the EBMT. (2021) (4)
- Posttransplantation Cyclophosphamide- and Sirolimus-Based Graft-Versus-Host-Disease Prophylaxis in Allogeneic Stem Cell Transplant Transplantation and Cellular Therapy (2021) (4)
- Loss of Mismatched HLA as a Mechanism of Leukemia Immune Escape in Family Haploidentical and Unrelated HSCT: Analysis of 103 Transplants From Alternative Donors. (2009) (4)
- Addition of a Single Low Dose of Anti T-Lymphocyte Globulin to Post-Transplant Cyclophosphamide after Allogeneic Hematopoietic Stem Cell Transplant: A Pilot Study (2022) (4)
- Outcome of allogeneic haematopoietic stem cell transplantation in myeloproliferative neoplasm, unclassifiable: a retrospective study by the Chronic Malignancies Working Party of the EBMT (2020) (4)
- Non-T depleted haploidentical stem cell transplantation in AML patients achieving first complete remission after one versus two induction courses: a study from the ALWP/EBMT (2022) (4)
- Complicated and persistent severe COVID-19 pneumonia in a recipient of allogeneic haematopoietic stem cell transplant (2021) (4)
- Outcomes following second allogeneic haematopoietic cell transplantation in patients with myelofibrosis: a retrospective study of the Chronic Malignancies Working Party of EBMT (2021) (4)
- Benefit of Rituximab Addition to High-Dose Programs with Autograft for B-Cell Lymphoma: A Multicenter GITIL Survey on 957 Patients. (2006) (4)
- Veno-occlusive Disease in HSCT Patients: Consensus-based Recommendations for Risk Assessment, Diagnosis, and Management by the GITMO Group. (2020) (4)
- Validation in a multicenter setting of Gitmo Criteria for identification of the poor mobilizer in multiple myeloma and lymphoma patients: preliminary analysis on 312 patients (2014) (4)
- The association of graft-versus-leukemia effect and graft-versus host disease in haploidentical transplantation with post-transplant cyclophosphamide for AML (2022) (3)
- Impact of Educational Interventions on Psychological Distress During Allogeneic Hematopoietic Stem Cell Transplantation: A Randomised Study (2020) (3)
- Improved Clinical Outcome of Adult Patients with Ph+ ALL After a Combined Imatinib-Chemotherapy Induction/Consolidation Program Followed by Allogeneic Hematopoietic Stem Cell Transplantation: Results From a Prospective Study of the Northern Italy Leukemia Group (2010) (3)
- Alternative Donors (Umbilical Cord Blood and Haploidentical Donors) for Allogeneic Stem Cell Transplantation in Relapsed / Refractory Hodgkin Lymphoma: A Retrospective Analysis of the EBMT Lymphoma Working Party and the Spanish Group of Stem Cell Transplantation (GETH) (2015) (3)
- mother donors improve outcomes after Hla haploidentical T cell-depleted hematopoietic transplantation: A Retrospective Study by the Cell Therapy and Immunobiology Working Party of the Ebmt : p076 (2016) (3)
- Dysglycemia after COVID-19 pneumonia: a six-month cohort study (2021) (3)
- Improvement in Cytokine Release Syndrome Management for the Treatment of AML Patients with Flotetuzumab, a CD123 x CD3 Bispecific Dart® Molecule for T-Cell Redirected Therapy (2019) (3)
- Integrated clinical role of echocardiography in patients with COVID-19 (2020) (3)
- Defibrotide for the Treatment of Hepatic Veno-Occlusive Disease/Sinusoidal Obstruction Syndrome Following Hematopoietic Stem Cell Transplantation or Chemotherapy--Results from the Italian Therapeutic Use Protocol (2015) (3)
- Defibrotide Prophylaxis of Sinusoidal Obstruction Syndrome in Adults Treated With Inotuzumab Ozogamicin Prior to Hematopoietic Stem Cell Transplantation (2022) (3)
- A Phase II Multicenter Trial of HSV-TK Engineered Donor Lymphocytes after Haplo-Identical HSCT: Early Immune Reconstitution and Abrogation of Gvhd. (2004) (3)
- AT-cell epitope encoded by a subset of HLA-DPB 1 alleles determines nonpermissive mismatches for hematologic stem cell transplantation (2004) (3)
- Inhibitor of DNA Binding 2 (ID2) Plays a Key Tumor Suppressor Role in Promoting Oncogenic Transformation in Multiple Myeloma (2018) (3)
- New drugs and allogeneic hematopoietic stem cell transplantation for hematological malignancies: do they have a role in bridging, consolidating or conditioning transplantation treatment? (2017) (3)
- Exploiting an Anti-CD3/CD33 Bispecific Antibody to Redirect Donor T Cells Against HLA Loss Leukemia Relapses (2019) (3)
- Treosulfan-Based Conditioning Regimen Prior to Allogeneic Stem Cell Transplantation: Long-Term Results From a Phase 2 Clinical Trial (2021) (3)
- Author Correction: Shape of (101955) Bennu indicative of a rubble pile with internal stiffness (2020) (3)
- RETINAL MICROVASCULAR CHANGES IN PATIENTS WITH ACUTE LEUKEMIA (2022) (3)
- Breakthrough Invasive Fungal Infections in Allogeneic Hematopoietic Stem Cell Transplantation (2021) (3)
- Immune-based Therapies for Hematological Malignancies: An Update by the EHA SWG on Immunotherapy of Hematological Malignancies (2020) (3)
- Letermovir reduces chronic GVHD risk in calcineurin inhibitor-free GVHD prophylaxis after hematopoietic cell transplantation (2022) (3)
- A virus-free cellular model recapitulates several features of severe COVID-19 (2021) (3)
- Dual Transgenesis of T Cells with a Novel CD44v6-Specific Chimeric Antigen Receptor and a Suicide Gene for Safe and Effective Targeting of Chemoresistance in Hematopoietic Tumors (2011) (3)
- Post-Transplant Cyclophosphamide Haplo-HSCT Revised: Peripheral Blood Stem Cell Graft and Sirolimus To Enhance Immune Reconstitution and Graft Versus Leukemia Effect In Patients With Active Leukemia (2013) (3)
- Treosulfan compared with reduced‐intensity busulfan improves allogeneic hematopoietic cell transplantation outcomes of older acute myeloid leukemia and myelodysplastic syndrome patients: Final analysis of a prospective randomized trial (2022) (3)
- Use of Defibrotide in Patients with COVID-19 Pneumonia; Results of the Defi-VID19 Phase 2 Trial (2021) (3)
- HLA Disparities Impact on Outcomes after Unmanipulated Haploidentical Hematopoietic Stem Cells Transplantation (HaploSCT) in Acute Leukemia: A Study from the Acute Leukemia Working Party of the European Group for Blood and Marrow Transplantation (EBMT) (2015) (3)
- Mother Donors Improve Outcomes after HLA Haploidentical Hematopoietic Transplantation: A Retrospective Study By the Cell Therapy and Immunobiology Working Party of the EBMT (2016) (3)
- Locoregional intrasplenic chemotherapy for hypersplenism in myelofibrosis (2001) (2)
- A second CD19 CAR T-cell infusion: yes or no? (2021) (2)
- Chronic anticoagulant treatment and risk of mortality in SARS-Cov2 patients: a large population-based study. (2022) (2)
- Human CD34+ Cells from Different Sources Disclose a Specific Stemness Signature (2016) (2)
- Infusions of HSV-TK Engineered Donor Lymphocytes Effectively Protect Patients Undergoing Haploidentical Stem Cells Trasplantation (HSCT) from Infectious Mortality. (2007) (2)
- In-Vivo Expansion of T Regulatory Cells by Rapamycin in a Calcineurin-Inhibitor Free GVHD Prophylaxis in Unmanipulated Haploidentical Stem Cell Transplantation (SCT) (2011) (2)
- Off-Tumor Target Expression Levels Do Not Predict CAR-T Cell Killing: A Foundation For The Safety Of CD44v6-Targeted T Cells (2013) (2)
- Reduced-Intensity Conditioning (RIC) Followed by Allogeneic Stem Cell Transplantation (SCT) for Relapsed Lymphomas: Impact of Pre-Transplantation Factors on Long-Term Outcome. (2005) (2)
- Rapamycin-Based GvHD Prophylaxis Is Effective in T-Cell Replete Unmanipulated Haploidentical Peripheral Stem Cell Transplantation for Advanced Haematological Malignancies: Results in 46 Patients. (2009) (2)
- Final Evaluation of a Clinical Phase III Trial Comparing Treosulfan to Busulfan-Based Conditioning Therapy Prior to Allogeneic Hematopoietic Stem Cell Transplantation of Adult Acute Myeloid Leukemia and Myelodysplastic Syndrome Patients Ineligible to Standard Myeloablative Regimens (2019) (2)
- Coronavirus Disease 2019 in Recipient of Allogeneic Hematopoietic Stem Cell Transplantation: Life-threating Features Within the Early Post-engraftment Phase (2020) (2)
- A Nomogram-Based Model to Predict Respiratory Dysfunction at 6 Months in Non-Critical COVID-19 Survivors (2022) (2)
- Chitinase-3-like protein-1 at hospital admission predicts COVID-19 outcome: a prospective cohort study (2022) (2)
- Efficacy, safety and feasibility of treatment of chronic HCV infection with directly acting agents in hematopoietic stem cell transplant recipients - study of Infectious Diseases Working Party of EBMT. (2021) (2)
- Family Mismatched Donor Transplantation for Myelofibrosis: A Retrospective Analysis of the EBMT Chronic Leukaemia Working Party (2016) (2)
- Pediatric-Type Therapy Including Lineage-Targeted Methotrexate to Improve Early Minimal Residual Disease Response and Survival In Adult Acute Lymphoblastic Leukemia (ALL): Interim Analysis of Northern Italy Leukemia Group Study 10/07 (2010) (2)
- Correction: Redefining and measuring transplant conditioning intensity in current era: a study in acute myeloid leukemia patients (2020) (2)
- Underdiagnosed Veno-Occlusive Disease/Sinusoidal Obstruction Syndrome(VOD/SOS) As a Major Cause of Multi-Organ Failure in Acute Leukemia Transplant Patients: An Analysis from the EBMT Acute Leukemia Working Party (2019) (2)
- A phase I-IIa study of genetically modified Tie-2 expressing monocytes in patients with glioblastoma multiforme (TEM-GBM Study). (2021) (2)
- Safety of third dose of COVID-19 vaccination in frail patients: Results from the prospective Italian VAX4FRAIL study (2022) (2)
- Quantitative polymerase chain reaction-based chimerism in bone marrow or peripheral blood to predict acute myeloid leukemia relapse in high-risk patients: results from the KIM-PB prospective study (2020) (2)
- Early Reconstitution of T-Cell Immunity to CMV After HLA-Haploidentical Hematopoietic Stem Cell Transplantation Is a Strong Surrogate Biomarker for Lower Non-Relapse Mortality Rates (2012) (2)
- Post‐remission intensive treatment after induction chemotherapy is feasible in selected elderly patients with acute myeloid leukemia and age ≥75 years: A retrospective analysis of the Rete Ematologica Lombarda (2015) (2)
- HSV-TK Engineered Donor Lymphocytes Add-Backs Reduce Late Mortality and Improve Survival of High Risk Acute Leukemia after Haplo-HSCT: Results of a Phase II Multicenter Trial. (2005) (2)
- Outcome of Third Salvage Autologous Stem Cell Transplantation in Multiple Myeloma (2016) (2)
- Optimal Thalassemia Free Survival and Minimal Regimen Related Toxicity in 50 Consecutive Transplants of High Risk Beta Thalassemia Pediatric Patients Using Myelablative Therapy with Intravenous Busulphan. (2008) (2)
- Cytomegalovirus in the transplant setting: Where are we now and what happens next? A report from the International CMV Symposium 2021 (2022) (2)
- T Cell Suicide Gene Therapy Prompts Thymic Renewal in Adults After Haploidentical Hematopoietic Stem Cell Transplantation in the Absence of Post-Transplant Immunesuppression (2011) (2)
- 995OInterim results from a phase 1 first-in-human study of flotetuzumab, a CD123 x CD3 bispecific DART molecule, in AML/MDS (2017) (2)
- Reply to A. Korfel et al. (2016) (2)
- Incidence, Risk Factors and Clinical Outcome Of Leukemia Relapses Due To Loss Of The Mismatched HLA Haplotype After Partially-Incompatible Hematopoietic Stem Cell Transplantation (2013) (2)
- Clofarabine and Treosulfan as Conditioning for Matched Related and Unrelated Hematopoietic Stem Cell Transplantation: Results from the Clo3o Phase II Trial (2020) (2)
- Acute Kidney Injury at Hospital Admission for SARS-CoV-2 Infection as a Marker of Poor Prognosis: Clinical Implications for Triage Risk Stratification (2022) (2)
- Safety and Efficacy of Idelalisib Treatment of Chronic Lymphocytic Leukemia (CLL) or Lymphoma Relapsing after Allogeneic Hematopoietic Cell Transplantation (alloHCT): A Survey By the EBMT Chronic Malignancies and Lymphoma Working Parties (2017) (2)
- Outcomes of Total Body Irradiation- Versus Chemotherapy-Based Myeloablative Conditioning Regimen in Haploidentical Hematopoietic Cell Transplantation with Post-Transplant Cyclophosphamide for Acute Lymphoblastic Leukemia: ALWP of the EBMT Study (2019) (2)
- Mapping the Evolution of the Mutational Landscape of Acute Myeloid Leukemia from Diagnosis to Post-Transplantation Relapse and Its Interplay with Immune Evasion Mechanisms (2019) (2)
- Haploidentical Hematopoietic Stem Cell Transplant Complicated by Atypical Hemolytic Uremic Syndrome and Kidney Transplant From the Same Donor With No Immunosuppression but C5 Inhibition (2019) (2)
- TCR Gene Editing Results in Effective Immunotherapy of Leukemia without the Development of GvHD (2011) (2)
- Graft-Versus-Leukemia Effect after Haplo-Identical Stem Cell Transplantation with Post-Transplant Cyclophosphamide in Patients with AML- No Association with Graft-Versus-Host Disease: A Study on Behalf of the Acute Leukemia Working Party of EBMT (2018) (2)
- Preliminary Results from a Phase Ib Study Exploring MDM2 Inhibitor Siremadlin (HDM201) in Combination with B-Cell Lymphoma-2 (BCL-2) Inhibitor Venetoclax in Patients with Acute Myeloid Leukemia (AML) or High-Risk Myelodysplastic Syndrome (HR-MDS) (2021) (2)
- Should anti-thymocyte globulin be added in post-transplant cyclophosphamide based matched unrelated donor peripheral blood stem cell transplantation for acute myeloid leukemia? A study on behalf of the Acute Leukemia Working Party of the EBMT (2022) (2)
- Prediction of allogeneic HSCT related mortality in acute leukemia: exploring boundaries of prediction through machine learning based modeling. A data mining study from the acute leukemia working party (ALWP) of the EBMT (2014) (2)
- Lack of efficacy of convalescent plasma in COVID‐19 patients with concomitant hematological malignancies: An Italian retrospective study (2022) (2)
- In Philadelphia Chromosome-Positive Acute Lymphoblastic Leukemia (Ph+ ALL) Imatinib (IM) and Chemotherapy in Combination Improve Remission Rate, Stem Cell Transplantation Rate and Long-Term Outcome (2012) (2)
- HLA-haploidentical transplantation for relapsed/refractory AML: better LFS with BM than with PBSC in patients ≥ 55 years of age. (2022) (2)
- GvHD Kinetics after Haploidentical TK-Cells: In-Vivo HSV-TK Suicide Machinery Is Effective in GvHD Control and Provide a Long-Term Immune-Suppressive Treatment-Free Survival (2014) (2)
- Acute Leukemia and High-Risk Myelodysplastic Syndromes in HIV-Positive Patients: 25-Years' Experience of the Rete Ematologica Lombarda (REL) (2019) (2)
- Peripheral blood stem and progenitor cell collection in pediatric candidates for ex vivo gene therapy: a 10-year series (2021) (2)
- When diagnostics meets translational research: detection of hemoglobin fractions in cellular lysates from in vitro erythroid cultures by Capillarys 2 Flex Piercing analyzer (Sebia). (2016) (2)
- Therapy-induced senescence upregulates antigen presentation machinery and triggers anti-tumor immunity in Acute Myeloid Leukemia (2022) (2)
- Elderly patients > 65 years of age with acute myeloid leukemia and normal karyotype benefit from intensive therapeutic programs (2016) (2)
- Graft-Versus-Leukemia Effect after Haplo-Identical Stem Cell Transplantation with Post-Transplant Cyclophosphamide in Patients with AML- No Association with Graft-Versus-Host Disease (GVHD): A Study on Behalf of the Acute Leukemia Working Party of EBMT. (2019) (2)
- Allogeneic Stem Cell Transplantation for Metastatic Renal Cell Cancer (RCC) (2011) (2)
- HLA Loss Leukemia Relapses after Partially-Incompatible Allogeneic HSCT As a Prototypical System to Investigate Natural Killer Cell Dynamics (2015) (2)
- Lentiviral hematopoietic stem and progenitor cell gene therapy provides durable clinical benefit in early-symptomatic early-juvenile metachromatic leukodystrophy (2021) (2)
- Pharmacokinetics (PK) Study Of Antithymocyte Globulins Fresenius (ATG-F) Prior To Allogeneic Stem Cell Transplantation: Implications For Timing Of Graft and Early Adoptive Immunotherapy Infusions (2013) (1)
- Efficacy of HSV-TK+ suicide gene donor lymphocytes after haploidentical transplantation (haplo-HSCT): Preliminary results of randomized TK008 study. (2014) (1)
- Impact of ABO-Mismatching Following HLA- Mismatched Unrelated Donor Hematopoietic Stem Cell Transplantation for AML—a Report From the ALWP of the EBMT (2017) (1)
- After Action Reviews of COVID‐19 response: Case study of a large tertiary care hospital in Italy (2021) (1)
- Nanosphere's Verigene® Blood Culture Assay to Detect Multidrug-Resistant Gram-Negative Bacterial Outbreak: A Prospective Study on 79 Hematological Patients in a Country with High Prevalence of Antimicrobial Resistance (2019) (1)
- Long-Term Immunological Profile of Patients Treated with Haploidentical HSCT and TK-Cells to Study the Requirements of Memory T Cell Persistence (2014) (1)
- A haploidentical may be a better choice than a female genoidentical donor to transplant a patient with high risk acute myelogenous leukemia in first remission (2019) (1)
- Effect of Bortezomib on the Autonomic Nervous System. (2006) (1)
- 132 RETROSPECTIVE ANALYSIS OF HIGH-RISK MYELODYSPLASTIC SYNDROME AND SECONDARY ACUTE MYELOID LEUKEMIA PATIENTS TREATED WITH ALLOGENEIC TRANSPLANTATION AT SAN RAFFAELE SCIENTIFIC INSTITUTE: A SINGLE CENTER EXPERIENCE (2015) (1)
- Allogeneic Bone Marrow Transplantation From Unrelated Donors in Multiple Myeloma: A Study from the Italian Bone Marrow Transplantation Donor Registry (2011) (1)
- MDM2 and Aurora Kinase a Contribute to SETD2 Loss of Function in Advanced Systemic Mastocytosis: Implications for Pathogenesis and Treatment (2018) (1)
- Allogeneic Hematopoietic Stem Cell Transplantation for Secondary Acute Myeloid Leukemia- a Report from the Acute Leukemia Working Party of the EBMT (2015) (1)
- NON-Permissive HLA-DPB1 T CELL Epitope Disparities Correlate with Engraftment and Survival after Unrelated Stem Cell Transplantation (2008) (1)
- Myeloablative Versus Reduced Intensity Conditioning Allogeneic Stem Cell Transplantation for Secondary Acute Myeloid Leukemia in Patients with Prior Myelodysplastic Syndrome/ Myeloproliferative Disorders: An ALWP of EBMT Study (2017) (1)
- Immune Reconstitution and Immune Correlates of Clinical Outcome IN Acute LEUKEMIA PATIENTS Treated with Haploidentical STEM CELL TRANSPLANTATION. (2009) (1)
- Human T cells engineered with a leukemia lipid-specific TCR enables donor-unrestricted recognition of CD1c-expressing leukemia (2021) (1)
- Human leukocyte antigen‐haploidentical transplantation for relapsed/refractory acute myeloid leukemia: Better leukemia‐free survival with bone marrow than with peripheral blood stem cells in patients ≥55 years of age (2022) (1)
- Outcome of Allogeneic Haematopoietic Stem Cell Transplantation in Myeloproliferative Neoplasms-Unclassifiable: A Retrospective Study By the Chronic Malignancies Working Party of EBMT (2019) (1)
- What's Next in CML - a Prospective Study Evaluating Sanger Sequencing and Next Generation Sequencing (NGS) for BCR-ABL1 Kinase Domain (KD) Mutation Screening (2017) (1)
- Graft-Versus-Host Disease after Haploidentical Stem Cell Transplantation in High Risk Haematological Diseases: A 10-Years Evaluation at San Raffaele Scientific Institute (2014) (1)
- Testosterone in males with COVID‐19: a 12‐month cohort study (2022) (1)
- Clofarabine and Treosulfan as conditioning for matched related and unrelated HSCT: results from the phase II trial "Clo3o". (2019) (1)
- Ropeginterferon Alfa-2b Versus Standard Therapy for Low-Risk Patients with Polycythemia Vera. Final Results of Low-PV Randomized Phase II Trial (2022) (1)
- Thromboembolism risk is higher among patients with diabetes and COVID-19 and is associated to poor clinical outcome (2021) (1)
- Long-term safety and survival outcomes after TK-expressing donor lymphocyte infusion (TK-DLI) in allogeneic hematopoietic stem cell transplantation (HSCT). (2013) (1)
- Physicians Abstracts (2016) (1)
- Management of Pain and Anxiety during Bone Marrow Aspiration: An Italian National Survey. (2020) (1)
- A longitudinal analysis of humoral, T cellular response and influencing factors in a cohort of healthcare workers: Implications for personalized SARS-CoV-2 vaccination strategies (2023) (1)
- OS05.6.A Modification of the tumor microenvironment in patients with glioblastoma using autologous, genetically modified, hematopoietic stem cell-based therapy: the TEM-GBM STUDY (NCT03866109) (2022) (1)
- Seasonal Betacoronavirus Antibodies’ Expansion Post-BNT161b2 Vaccination Associates with Reduced SARS-CoV-2 VoC Neutralization (2022) (1)
- Coadministration of letermovir and sirolimus in allogeneic hematopoietic cell transplant recipients (2021) (1)
- Levofloxacin prophylaxis vs no prophylaxis in neutropenic patients within an endemic country for carbapenem-resistant GNB. (2022) (1)
- Post-Transplant Treatment with Ponatinib for Patients with High-Risk Philadelphia Chromosome Positive Leukemia (2016) (1)
- Impact of Remdesivir on SARS-CoV-2 Clearance in a Real-Life Setting: A Matched-Cohort Study (2022) (1)
- GVHD occurrence does not reduce AML relapse following PTCy-based haploidentical transplantation: a study from the ALWP of the EBMT (2023) (1)
- Early Response Dynamics Including Minimal Residual Disease (MRD) and Adherence to Risk/MRD-Oriented Therapy Are Major Outcome Determinants in Adult Ph-Negative Acute Lymphoblastic Leukemia (ALL). (2012) (1)
- A Randomized Trial of Rabbit Anti-Thymocyte Globulin, Given on Day+7 after Alternative Donor Transplants. (2006) (1)
- ENHANCED ALLOREACTIVITY TO BI-DIRECTIONAL NON-PERMISSIVE HLA-DPB1 MISMATCHES SUPPORTS NON-HIERARCHICAL T-CELL EPITOPE GROUP DIVERSITY AS UNDERLYING BIOLOGICAL MECHANISM (2013) (1)
- Incidence of Secondary Myelodysplastic Syndrome/Acute Leukemia in 1,266 Lymphoma Patients Following High-Dose Therapy and Autograft: A Study from GITIL (Gruppo Italiano Terapie Innovative nei Linfomi). (2006) (1)
- Driver Somatic Mutations and Transplantation Decision Making in Patients with Myelodysplastic Syndrome (2016) (1)
- After Action Reviews to assess COVID-19 hospital responses (2021) (1)
- R‐CHOP PRECEDED BY ENGINEERED TUMOR NECROSIS FACTOR (TNF) IN RELAPSED OR REFRACTORY PRIMARY DIFFUSE LARGE B‐CELL LYMPHOMA OF THE CNS (rPCNSL): FINAL RESULTS OF THE INGRID TRIAL (2019) (1)
- Effect of prophylactic or pre-emptive use of tyrosine kinase inhibitors post-Allo SCT in bcr-abl positive acute lymphoblastic leukemia: a subanalysis of GITMO ph-positive ALL study (2022) (1)
- IN ADULT ACUTE MYELOID LEUKAEMIA (AML) ALL RISK SUBSETS BENEFIT FROM A SEQUENTIAL HIGH-DOSE PROGRAMME AS EARLY RESCUE OF FIRST INDUCTION FAILURE: A REPORT FROM NORTHERN ITALY LEUKAEMIA GROUP (NILG) (2010) (1)
- Refined Disease Risk Index (DRI) and Hematopoietic Cell Transplantation Comorbidity Index (HCT-CI) Predict Survival after Haploidentical Stem Cell Transplantation: A Comparative Study with EBMT Risk Score in 220 Consecutive Patients (2015) (1)
- Matching of MHC Class I Chain-Related Genes a and B Is Associated with Reduced Incidence of Severe Acute Graft-Versus-Host Disease after Unrelated Hematopoietic Stem Cell Transplantation (2014) (1)
- New drugs and allogeneic hematopoietic cell transplantation for hematological malignancies: potential roles as bridge to transplant, as consolidation or as part of the conditioning (2017) (1)
- Isatuximab Short-Duration Fixed-Volume Infusion Plus Bortezomib (V) Lenalidomide (R) and Dexamethasone(d) Combined Therapy for Newly Diagnosed Multiple Myeloma (NDMM): Results from a Phase 1b Feasibility/Safety Study (2020) (1)
- Endocrinopathies Following Allogeneic Stem Cell Transplantation: 10 Years Follow-up in 402 Patients (2018) (1)
- Outcomes of Total Body Irradiation- Versus Chemotherapy-Based Myeloablative Conditioning Regimen in Haploidentical Hematopoietic Cell Transplantation with Post-Transplant Cyclophosphamide for Acute Myelogenous Leukemia: ALWP of the EBMT Study (2019) (1)
- BAT2 and BAT3 polymorphisms as novel genetic risk factors for rejection after HLA-related SCT (2014) (1)
- Addition of Rituximab in Reduced Intensity Conditioning Regimens for B-Cell Malignancies Does Not Influence Transplant Outcomes: EBMT Registry Analyses Following Allogeneic Stem Cell Transplantation for B-Cell Malignancies (2021) (1)
- Immune Senescence and Exhaustion Correlate with Response to Flotetuzumab, an Investigational CD123×CD3 Bispecific Dart® Molecule, in Acute Myeloid Leukemia (2020) (1)
- Allogeneic Hematopoietic Stem Cell Transplantation For Severe Neuromyelitis Optica (2013) (1)
- Favourable Outcome after Treosulfan Based Conditioning in Patients Undergoing an Allogeneic Hematopoietic Cell Transplantation (alloHCT) for the Treatment of Acute Myleloid Leukaemia (AML): A Subgroup Analysis of the Randomized Phase III MC-Fludt.14/L Trial (2022) (1)
- Combined plasma levels of IL‐10 and testosterone, but not soluble HLA‐G5, predict the risk of death in COVID‐19 patients (2022) (1)
- Allogeneic Stem Cell Transplantation (Allo-SCT) Following a Reduced-Intensity Conditioning (RIC) Regimen in Relapsed Peripheral T-Cell Lymphomas (PTCL): Results at 4 Year of Median Follow-up. (2009) (1)
- Clinical implementation of low-dose total body irradiation using topotherapy technique (2019) (1)
- Prognostic factors for neutrophil engraftment after haploidentical cell transplantation with PT-Cy in patients with acute myeloid leukemia in complete remission, on behalf of the ALWP-EBMT (2021) (1)
- Acute respiratory distress in a neutropenic febrile patient after hematopoietic cell transplantation. (2013) (1)
- Platelet activation state in early stages of Covid-19. (2022) (1)
- Impact of conditioning regimen intensity on outcomes of second allogeneic hematopoietic cell transplantation for secondary acute myelogenous leukemia (2022) (1)
- Droplet Digital PCR for DNMT3A and IDH1/2 Mutations to Improve Early Diagnosis of Acute Myeloid Leukemia Relapse after Allogeneic HSCT (2014) (1)
- INO-CD22: A Multi-Center, Real-Life Study on Inotuzumab-Ozogamicin Safety and Effectiveness in Adult Patients with Relapsed/Refractory Acute Lymphoblastic Leukemia (2021) (1)
- The role of pharmacies in haematopoietic stem cell transplantation process: A nationwide survey by Gruppo Italiano Trapianto di Midollo Osseo (2021) (1)
- In Adult Acute Lymphoblastic Leukemia (ALL) Different Minimal Residual Disease (MRD) Levels Predict Clinical Outcome in All Patients and Response to Allogeneic/Autologous Transplantation in MRD-Positive Patients. (2012) (1)
- Sirolimus and Post Transplant Cyclophosphamide (PT-Cy) Allow the Use of Haploidentical PBSC Grafts Inducing a Favorable Immune Reconstitution with Low Rates of GvHD: Results in 39 Patients (2014) (1)
- Pre-Transplant Ferritin, Albumin and Platelet Count Add Prognostic Information to Comorbidities for Allogeneic Hematopoietic Cell Transplantation (HCT) Outcomes: A Multi-Center Discovery-Validation Study (2014) (1)
- How to obtain severe hypoglycemia without causing brain or cardiac damage. (2019) (1)
- Second allogeneic transplants for multiple myeloma: a report from the EBMT Chronic Malignancies Working Party (2021) (1)
- remission at transplantation in adults with high-risk acute leukemia : a risk factor analysis of A survey of fully haploidentical hematopoietic stem cell transplantation (2008) (1)
- Effect of Age and Previous Autologous Transplant on Treatment-Related Mortality and GVHD in 140 Patients Treated with Reduce-Intensity Conditioning and Allograft for Advanced Hematological Malignancies. (2004) (1)
- 819. Molecular Follow-Up of Patients Treated with Allogeneic Hematopoietic Stem Cell Transplantation and Donor Lymphocytes Transduced with a Retroviral Vector Expressing HSV-TK and |[Delta]|LNGFR (2005) (1)
- Raman spectroscopy for the assessment of acute myeloid leukemia: a proof of concept study (2014) (1)
- High-dose sequential chemotherapy and rituximab (R-HDS) supported by autologous stem cell transplantation (ASCT) in patients (pts) with systemic B-cell lymphoma with CNS involvement (SCNSL) at diagnosis or relapse: Interim analysis of feasibility and activity of a phase II trial. (2010) (1)
- Voriconazole and Non-Melanoma Skin Cancer after Allogeneic HSCT: Results of a Prospective Dedicated Follow-up Program in 302 Patients (2016) (1)
- Immune Reconstitution-Based Score for Risk Stratification of Chronic Graft-Versus-Host Disease Patients (2021) (1)
- CXCL10 levels at hospital admission predict COVID-19 outcome: hierarchical assessment of 53 putative inflammatory biomarkers in an observational study (2021) (1)
- Complement as a target in COVID-19? (2020) (1)
- Machine learning based predictive modeling for mortality 100 days post allogeneic hematopoietic stem cell transplantation (ALLO-HSCT) in acute leukemia: an EBMT-acute leukemia working party (ALWP) registry study (2014) (1)
- Study of the Kotka Crater and Its Ejecta Dynamics (2017) (1)
- High Doses of Antimetabolites Followed By High-Dose Sequential Chemoimmunotherapy and Autologous Stem Cell Transplant in Patients with Systemic B-Cell Lymphoma and Secondary Central Nervous System Involvement: Final Results of a Multicenter Phase II Trial (2014) (1)
- Blood-Brain Barrier Permeabilization with Engineered Tumor Necrosis Factor-α Followed by R-CHOP Is an Active and Safe Salvage Therapy in Primary CNS Lymphoma (2020) (1)
- COVID-BioB Cohort Study: the neutralizing antibody response to SARS-CoV-2 in symptomatic COVID-19 is persistent and critical for virus control and survival. (2021) (1)
- P010 Incidence and risk factors of secondary myelodysplastic syndrome/acute leukemia occurrence following peripheral blood progenitor cell autograft: a GITIL (Gruppo Italiano Terapie Innovative Nei Linfomi) survey on 1266 lymphoma patients (2007) (1)
- Predictive Limitations of Hematopoietic Stem Cell Transplantation Associated Mortality: A Machine Learning in-Silico Analysis of the EBMT - Acute Leukemia Working Party Registry (2015) (1)
- The Impact of Amino Acid Variability Defines a Functional Distance Predictive of Permissive HLA-DPB1 Mismatches in Hematopoietic Cell Transplantation (2015) (1)
- Treosulfan Based Myeloablative Regimen Provides High Rate Of Allogeneic Engraftment and Low Toxicity In Patients With Advanced Myelofibrosis (2013) (1)
- Levels of Minimal Residual Disease Prior to Transplant Influence Outcome of Adult Patients with Philadelphia Chromosome Positive Acute Lymphoblastic Leukemia (2015) (1)
- T Repleted Haploidentical Mismatch Allogeneic Versus Autologous Hematopoietic Stem Cell Transplantation In Adult Patients With Acute Leukemia In Complete Remission (CR): A pair-Matched Analysis From The Acute Leukemia Working Party Of EBMT (2013) (1)
- The Role of Donor Selection for a Second Allogeneic Stem Cell Transplantation in Patients with AML Relapsing after a First Transplant; A Study on Behalf of the Acute Leukemia Working Party of EBMT (2018) (1)
- Post-Transplant Cyclophosphamide for Graft Vs Host Disease Prophylaxis in Multiple Myeloma Patients Who Underwent Allogeneic Hematopoietic Cell Transplantation: First Comparison By Donor Type; A Study from the Chronic Malignancies Working Party of the EBMT (2020) (1)
- Outcomes Following Second Allogenic Haematopoietic Cell Transplantation in Patients with Myelofibrosis: A Retrospective Study on Behalf of the Chronic Malignancies Working Party of EBMT (2019) (1)
- Clinical Impact of an Accurate Genetic Characterization of Older Acute Myeloid Leukemia Patients: A Report from the Northern Italy Leukemia Group (NILG) Randomized Trial 02/06 (2018) (1)
- CTIM-24. AUTOLOGOUS CD34+ ENRICHED HEMATOPOIETIC PROGENITOR CELLS GENETICALLY MODIFIED FOR HUMAN INTERFERON-α2, ARE WELL TOLERATED & RAPIDLY ENGRAFT IN PATIENTS WITH GLIOBLASTOMA MULTIFORME (TEM-GBM_001 STUDY) (2020) (1)
- Title: Achieving a Molecular Remission before Allogeneic Stem Cell Transplantation in Adult Patients with Philadelphia Chromosome Positive Acute Lymphoblastic Leukemia: Impact on Relapse and Long Term Outcome (2016) (1)
- Integrated Epigenetic Profiling Identifies EZH2 As a Therapeutic Target to Re-Establish Immune Recognition of Leukemia Relapses with Loss of HLA Class II Expression (2019) (1)
- Autoantibody Production during Chronic Graft-Versus-Host Disease Does Not Associate with Long-Term Persistence of Host B Cells in Humans (2008) (1)
- Allogeneic hematopoietic stem cell transplantation in patients older than 65 years with acute myeloid leukemia and myelodysplastic syndrome: a 15-year experience (2021) (1)
- Allografting for patients with advanced hematological malignancies: non-myeloablative conditioning followed by the reinfusion of lymphocytes engineered with hsv thymidine kinase gene (2000) (1)
- The in vivo targeting of tumor antigens to DCs by administration of transduced autologous lymphocytes results in robust and prolonged immunization: Pre-clinical validation and results of a pilot clinical studies of vaccination for metastatic melanoma. (2006) (1)
- The EHA Research Roadmap: Immune-based Therapies for Hematological Malignancies (2021) (1)
- Infection-Related Mortality (IRM) after Allogeneic Hematopoietic Stem Cell Transplantation: Age, CMV Status, Pre-Transplant IgA and IgM Levels Predict IRM and Survival in a New Clinico-Biological Scoring System Developed in 492 Consecutive Patients (2016) (1)
- Minimal Residual Disease (MRD) and Risk-Oriented Therapy in Adult Acute Lymphoblastic Leukemia (ALL). (2005) (1)
- TEM-GBM: An Open-Label, Phase I/IIa Dose-Escalation Study Evaluating the Safety and Efficacy of Genetically Modified Tie-2 Expressing Monocytes to Deliver IFN-α within Glioblastoma Tumor Microenvironment (2021) (1)
- High-Sensitivity Hematopoietic Chimerism By qPCR For Relapse Prediction and Specific Identification Of HLA Loss Leukemic Variants (2013) (1)
- Donor Age Determines Outcome in Acute Leukemia Patients Undergoing Haploidentical Hematopoietic Cell Transplantation (2017) (1)
- Pre-Transplant Colonization By a Multidrug-Resistant Gram Negative Bacteria Has No Impact on Overall Survival and Mortality after Hematopoietic Stem Cell Transplantation: A Single-Center Experience in 362 Patients (2016) (1)
- 1559. Hematopoietic Cell Transplantation with Post-transplant Cyclophosphamide: Impact of Donor Type on Pre-engraftment Blood-Stream Infections (2018) (1)
- PO-0868 Total Marrow Irradiation in Myeloma Multiple patients candidate to allogeneic transplant (2019) (1)
- Identification of a Chromatin-Splicing Mutational Signature to Define Secondary Acute Myeloid Leukemia: A Report from the Northern Italy Leukemia Group (NILG) Prospective Trial 02/06 (2019) (1)
- Comparison of HLA-mismatched unrelated donor transplantation with post-transplant cyclophosphamide versus HLA-haploidentical transplantation in patients with active acute myeloid leukemia (2022) (1)
- Clinical and molecular remission following reduced intensity conditioning and allogeneic transplantation in a patient with refractory multiple myeloma. (2002) (1)
- Post‐transplant cyclophosphamide in acute leukemia patients receiving more than 5/10 HLA‐mismatched allogeneic hematopoietic cell transplantation from related donors: A study on behalf of the ALWP of the EBMT (2022) (1)
- Impact of Cytogenetic Risk on Outcomes of Non-T Cell Depleted Haploidentical Hematopoietic Cell Transplantation in Patients with Relapsed or Refractory Acute Myeloid Leukemia. (2022) (1)
- Frequency and Impact of Pre-Transplant Somatic Co-Occurring Mutations on Clinical Outcomes of Acute Myeloid Leukemia Patients Receiving Allogeneic Hematopoietic Stem Cell Transplantation: On Behalf of the EBMT Acute Leukemia Working Party (2022) (1)
- Working Parties (1992) (1)
- Improved Survival After Allogeneic Hematopoietic Stem Cell Transplantation for Metastatic Renal Cancer Associated with Homozygosity for the HLA-G 14 Base-Pair Deletion Polymorphism: An EBMT STWP Study (2012) (1)
- A Plastic SQSTM1/p62-Dependent Autophagic Reserve Maintains Protein Homeostasis and Determines Proteasome Inhibitor Susceptibility in Multiple Myeloma Cells (2015) (1)
- Haploidentical Transplantation Outcome Is Not Inferior to Standard Matched Related and Unrelated Donor Transplantation: An Intention-to-Treat Analysis of 241 Patients with Acute Myeloid Leukemia (2012) (1)
- Editorial: Strengths and Challenges of Allo-SCT in the Modern Era (2022) (1)
- Revealing the Generation of Human Memory Stem T Cells in Haploidentical T-Replete Hematopoietic Stem Cell Transplantation (2014) (1)
- Cidofovir Treatmenf For Hemorrhagic Cystitis After Allogeneic Hematopoietic Stem Cell Transplantation For High Risk Hematological Malignancies (2013) (1)
- Modeling Antileukemic Adoptive Immunotherapy In Mouse-Humans Chimeras To Identify Novel Mechanisms Of Cancer Immunoediting (2013) (1)
- Early molecular diagnosis of aspergillosis in a patient with acute myeloid leukaemia (2014) (1)
- Case Report: Consistent disease manifestations with a staggered time course in two identical twins affected by adenosine deaminase 2 deficiency (2022) (1)
- NTLA5001, a T Cell Product Candidate with CRISPR-Based Targeted Insertion of a High-Avidity, Natural, WT1-Specific TCR, Shows Efficacy in In Vivo Models of AML and ALL (2020) (1)
- Is There a Stronger Graft-Versus-Leukemia Effect Using HLA-Haplo-Identical Donors Compared to HLA-Identical Sibling Donors? (2015) (1)
- Temporal, Quantitative and Functional Characteristics of Single-KIR Positive Alloreactive NK Cell Recovery Account for Impaired Graft Versus Leukemia Activity after Haploidentical HSCT. (2007) (1)
- Cytomegalovirus-specific T cells restricted for shared and donor human leukocyte antigens differentially impact on Cytomegalovirus reactivation risk after allogeneichematopoietic stem cell transplantation. (2022) (1)
- Impact of dose intensity on unrelated cord blood transplantation outcomes in adults patients with acute leukemia: A Report from Eurocord, the ALWP and the Cord Blood Committee of the CTIWP of the EBMT (2016) (1)
- Non-T Depleted Haploidentical Transplantation with Post-Transplantation Cyclophosphamide in Patients with Secondary Versus De Novo AML: A Study from the Acute Leukaemia Working Party of the European Society for Blood and Marrow Transplantation (EBMT) (2023) (1)
- Busulfan (Bu) Plus Cyclophosphamide (Cy) Versus TBI Plus Cy Conditioning for Allogeneic Stem Cell Transplantation (alloSCT) From Matched Unrelated Donors (MUD) In Adult Patients with AML in First Relapse: A Survey From the Acute Leukemia Working Party of EBMT (2011) (1)
- Case Report: Invasive Fungal Infection and Daratumumab: A Case Series and Review of Literature (2022) (1)
- 147 Involvement in treatment decisions, desire for prognostic information and quality of life in high-risk myelodysplastic syndromes: the physician's perspective (2011) (1)
- Gimema AML1718 Part 1: Planned Interim Analysis of a Safety Run-in and Phase 2 Open-Label Study of Venetoclax, Fludarabine, Idarubicin and Cytarabine (V-FLAI) in the Induction Therapy of Non Low-Risk Acute Myeloid Leukemia (2022) (1)
- Correction to: Can Cytokine Blocking Prevent Depression in COVID-19 Survivors? (2021) (1)
- Treatment of Individuals with Severe Sickle Cell Disease with OTQ923, an Autologous, Ex Vivo, CRISPR/Cas9-Edited, CD34+ Hematopoietic Stem and Progenitor Cell Product, Leads to Durable Engraftment and Fetal Hemoglobin Induction (2022) (1)
- Pentraxin 3 As a Novel Diagnostic and Prognostic Biomarker for Acute GvHD and Fungal Infections in Adult Allogeneic HSCT Recipients (2016) (1)
- Molecular Remission Can Be Attained in Relapsed or Refractory Chronic Lymphocytic Leukemia (CLL) and Follicular Lymphomas after Reduced Intensity Conditioning (RIC) and Allogeneic Stem Cell Transplantation (ALLO-SCT). (2004) (1)
- Therapy-Induced Senescence As an Anti-Cancer and Immune-Stimulatory Strategy (2021) (1)
- Safety and Efficacy of Donor T Cells Engineered with Herpes Simplex Virus Thymidine-Kinase Suicide Gene (TK Cells) Given after T-Cell Depleted (TCD) Haploidentical Hematopoietic Transplantation (Haplo-HSCT): Results of a 14-Year Follow-Up in 45 Patients (2017) (1)
- Correction to: Can Cytokine Blocking Prevent Depression in COVID-19 Survivors? (2021) (0)
- Practice harmonization workshops of EBMT: an expert-based approach to generate practical and contemporary guidelines within the arena of hematopoietic cell transplantation and cellular therapy. (2023) (0)
- transplantation factor for mortality after unrelated hematopoietic stem cell Nonpermissive HLA-DPB1 disparity is a significant independent risk (2013) (0)
- Metabolomics Identifies Potential Biomarkers of Multiple Myeloma Development and Progression (2012) (0)
- Influence of Stem Cell Source (Bone Marrow versus Peripheral Blood) on Outcome after Reduced-Intensity Conditioning Regimens for Acute Leukemia—a Report from the Acute Leukemia Working Party of the EBMT (2015) (0)
- CLRM-08 TARGETING IMMUNE-PAYLOAD TO THE GLIOBLASTOMA TUMOR MICROENVIRONMENT USING A MACROPHAGE-BASED TREATMENT RELYING ON AUTOLOGOUS, GENETICALLY MODIFIED, HEMATOPOIETIC STEM CELL-BASED THERAPY: THE TEM-GBM STUDY (NCT03866109) (2022) (0)
- Acinar ventilation heterogeneity (Sacin) assessed by nitrogen multiple breath washout is an accurate and sensitive marker of bronchiolitis obliterans (BO) (2014) (0)
- Unrelated Cord Blood Versus Non-T Cell Depleted Haploidentical Stem Cell Transplantation: Comparable Results in Adults with Acute Leukemia, a Eurocord and ALWP-EBMT Study (2014) (0)
- Preexisting and new-onset diabetes in patients with COVID-19 pneumonia (2021) (0)
- University of Groningen In Vivo Tracking of Human Hematopoiesis Reveals Patterns of Clonal Dynamics during Early and Steady-State Reconstitution Phases Biasco, (0)
- Patients Reported Outcomes (PROs) Are Still Unsatisfactory Among AML Long-Term Survivors: The Impact of Chronic GvHD in a Prospective Study on 15 Years Transplant Activity (2022) (0)
- Outcomes of Acute Myelogenous Leukemia Patients Undergoing Haploidentical Hematopoietic Cell Transplantation with Post-Transplant Cyclophosphamide: Impact of Total Body Irradiation Versus Chemotherapy-Based Myeloablative Conditioning (2020) (0)
- Post-Transplant Cyclophosphamide Versus Antithymocyte Globulin in Patients with Acute Myeloid Leukemia Undergoing Allogeneic Stem Cell Transplantation from HLA-Identical Sibling Donors: A Retrospective Analysis from the Acute Leukemia Working Party of the EBMT (2019) (0)
- P4.35 Outcome measures validation study for mesoangioblasts transplantation in children affected by Duchenne muscular dystrophy (2010) (0)
- Patients with aaIPI 2-3 Diffuse Large B-Cell Lymphoma Achieve 75% Long-Term Survival Following First-Line Rituximab-Supplemented High-Dose Sequential Chemotherapy and Autograft: Final Results of the Prospective Phase II GITIL (Gruppo Italiano Terapie Innovative nei Linfomi) Trial. (2007) (0)
- Treosulfan and fludarabine as a myeloablative and reduced toxicity conditioning regimen in allogeneic hematopoietic stem cell transplantation (2008) (0)
- Dissecting Ex Vivo Expansion of Mobilized Peripheral Blood Hematopoietic Stem and Progenitor Cells By Single Cell RNA Sequencing (2018) (0)
- Monkeypox infection in a hemopoietic stem cell and heart transplant recipient (2022) (0)
- Primary tumor cells show specific susceptibility to KIR-incompatible NK-cell mediated lysis in an ex- vivo single cell cytotoxic assay (SCCA) (2005) (0)
- Clinical and Biological Features Associated with Engraftment of Acute Myeloid Leukemia Patient-Derived Xenografts (2016) (0)
- Early Blast Clearance Evaluation after Induction Chemotherapy for Acute Myeloid Leukemia By Multiparameter Flow Cytometry and WT1-RNA Quantification: A Single Center Experience (2014) (0)
- Post-Chemotherapy Brain Irradiation in Primary CNS Lymphomas: Impact on Survival of Different Fields and Doses. (2009) (0)
- Implementing a new conditioning regimen for allogeneic stem celltransplantation: objectives and key factors for an experimental approach (2009) (0)
- Intraocular lymphoma (IOL): Treatment and outcome in hiv- patients (2000) (0)
- Monitoring of Wilms9 Tumor Gene 1 Levels Predict Early Relapse After Allogeneic Hematopoietic Stem Cells Transplantation in Patients with High Risk Acute Myeloid Leukemia and Myelodysplastic Syndrome (2011) (0)
- Effect of Related and Unrelated Donor Haematopoietic Stem-Cell Transplantation on Outcome in Adults With High Risk Hematological Disease: An intention-to-treat Analysis of 410 Patients at a Single Center Institution (2011) (0)
- Allografting from unrelated donors in multiple myeloma: a study by the Italian bone marrow donor registry (2012) (0)
- The Nurses Group Oral Sessions (2016) (0)
- Physical Properties of an Unweathered CO Chondrite Fall, Moss (2019) (0)
- Disease Risk Index (DRI) Score Stratification and Composite End-Point GvHD-Free Relapse-Free Survival (GRFS) May Optimize Transplant Decision-Making Process in Haploidentical Stem Cell Transplantation (2016) (0)
- In vivo tracking of human hematopoiesis reveals patterns of clonal dynamics during early post-transplant and steady-state reconstitution phases (2018) (0)
- Total body irradiation versus busulfan based intermediate intensity conditioning for stem cell transplantation in ALL patients >45 years-a registry-based study by the Acute Leukemia Working Party of the EBMT. (2023) (0)
- The 48th Annual Meeting of the European Society for Blood and Marrow Transplantation: Physicians Award Winners (O001-O007) (2022) (0)
- Allogeneic bone marrow transplantation in HIV people with hematological malignancies: Post‐transplant cyclophosphamide to overcome the HLA‐matching barrier (2020) (0)
- Tuesday, March 28th 16:30-18:00 Oral 13: MRD, chimerism and immune reconstitution A Rapid and Sensitive Molecular Tool for the Early Diagnosis of HLA Loss Relapses after Partially- Incompatible Allogeneic HSCT (2017) (0)
- P154 Combination of fludarabine and cytarabine as induction treatment of poor prognosis myelodysplastic syndrome (MDS) and secondary acute myeloid leukaemia (sAML): a single centre experience (2007) (0)
- A Multi-Center, Multinational, Prospective Observational Registry Study of Defibrotide in Patients Diagnosed with Severe Veno-Occlusive Disease/Sinusoidal Obstruction Syndrome (VOD/SOS) after Hematopoietic Cell Transplantation (HCT) (2019) (0)
- The hierarchy of alternative donors for allogeneic hematopoietic stem cell transplantation in poor risk Aml in CR1 revisited (2016) (0)
- Impact of CD34+ Cell Dose on Clinical Outcomes after Allogeneic Peripheral Blood Hematopoietic Cell Transplantation from Haploidentical Donors in AML Patients. a Study from the Acute Leukemia Working Party of the European Society for Blood and Marrow Transplantation (EBMT) (2020) (0)
- Reduced 8-Gray Compared to Standard 12-Gray Total Body Irradiation for Allogeneic Transplantation in First Remission Acute Lymphoblastic Leukemia: A Study of the Acute Leukemia Working Party of the EBMT (2023) (0)
- Rapid Detection of Pathogens Causing Sepsis in Neutropenic Hematologic Patients by a Multiplex PCR-Based Assay (2011) (0)
- YTB323 (Rapcabtagene Autoleucel) Demonstrates Durable Efficacy and a Manageable Safety Profile in Patients with Relapsed/Refractory Diffuse Large B-Cell Lymphoma: Phase I Study Update (2022) (0)
- In Systemic Masocytosis, Midostaurin Targets Both Kit and Aurora Kinase a Reverting H3K36Me3 Deficiency and Synergizes with Second-Generation Tyrosine Kinase Inhibitors (2019) (0)
- A phase II study on intensive all type chemotherapy with minimal residual disease (MRD) oriented postremission strategy in adult patients with lymphoblastic lymphoma(PROTOCOL NILG-ALL NO.09/00) (2008) (0)
- Case report: Intravitreal methotrexate in intraocular acute lymphoblastic leukemia (2022) (0)
- MRD in Venetoclax-Based Treatment for AML: Does it Really Matter? (2022) (0)
- Intensive treatment of elderly patients with acute myeloid leukemia or myelodysplastic syndrome: A single center experience in 63 patients (2012) (0)
- Ventilation Heterogeneity Of Peripheral Airways (Sacin*VT) Assessed By Nitrogen Multiple Breath Washout (N2-MBW) Is An Accurate and Sensitive Marker Of Bronchiolitis Obliterans Following Haematopoietic Stem Cell Transplantation Recipients (2013) (0)
- Refined graft-versus-host disease-free/relapse-free survival - a novel outcome endpoint for haploidentical transplantation in adults with acute leukemia: on behalf of ALWP-EBMT (2016) (0)
- Allogeneic stem cells transplantation in elderly patients suffering from high risk hematological malignancies: results with reduced toxicity conditioning regimen. (2008) (0)
- Missing HLA C Group 1 Ligand In Patients With AML and MDS Is Associated With Reduced Risk Of Relapse After Allogeneic Stem Cell Transplantation With Fludarabine and Treosulfan Reduced Toxicity Conditioning (2013) (0)
- 648 Autologous macrophage-based immunotherapy Induces a pro-inflammatory state in GBM tumor microenvironment – (TEM-GBM) (2022) (0)
- Monocytes Are Required for Both Optimal Anti-Leukemic Efficacy and the Cytokine Release Syndrome By CAR-T Cells: Lessons from an Innovative Xenotolerant Mouse Model (2016) (0)
- Haploidentical HSCT (2018) (0)
- Incremental Innovation of Ex Vivo Hematopoietic Stem Cell Engineering to Expand Clinical Gene Therapy Applications (2016) (0)
- Combining Whole Exome Sequencing and Rnaseq to Provide a Comprehensive Landscape of the Mechanisms of Post-Transplantation Leukemia Relapse (2018) (0)
- Early and Effective Immune-Recovery by Gene-Engineered Lymphocytes after Haploidentical Transplantation for Leukemia Abate Late Transplant Mortality (2008) (0)
- Graft-Versus-Leukemia Effect Is Independent from Graft-Versus-Host Disease Following Ptcy-Based HLA-Haploidentical Transplantation (2022) (0)
- Adaptive Routes of Hematopoietic Stem Cell Differentiation to Disease Conditions and Age in Gene Therapy Patients (2022) (0)
- Human herpesvirus 6-specific T-cell immunity in allogeneic hematopoietic stem cell transplant recipients. (2023) (0)
- Author's response to reviews Title: Health related quality of life in Middle-Eastern children with beta- thalassemia Authors: (2012) (0)
- 379TiP TEM-GBM: A phase I-IIa clinical study of genetically modified Tie-2-expressing monocytes in patients with glioblastoma multiforme (2021) (0)
- 111-P: Loss of Mismatched HLA in Family Haploidentical and Unrelated HSCT (2010) (0)
- Epitope-Specific Typing (EST) for HLA-DPB1 Matching: Proof of Principle for an Innovative Approach to Unrelated Hematopoietic Stem Cell Donor Selection. (2006) (0)
- Graft Versus Leukemia With Little Graft Versus Host Disease? Long Term Follow-Up Of a Study Using Transduced Donor T-Cells For Donor Leukocyte Transfusion (2013) (0)
- Bone marrow central memory and memory stem T-cell exhaustion in AML patients relapsing after HSCT (2019) (0)
- Exhausted Central Memory and Memory Stem T Cells Specific for Leukemia Infiltrate the Bone Marrow of AML Patients Relapsing after Allogeneic HSCT (2018) (0)
- CD4 CAR-T cells targeting CD19 play a key role in exacerbating cytokine release syndrome, while maintaining long-term responses (2023) (0)
- Thymic renewal and antileukemic effect in adults after haploidentical transplantation and suicide gene therapy. (2010) (0)
- Implementation of An Alternative Donor Option Is Prerequisite for a Good Intention-to-Treat (ITT) In Patients In Need of Allogeneic Transplantation: Analysis of 410 Patients (2010) (0)
- Outcome measures validation study for mesoangioblasts transplantation in children affected by Duchenne Muscular Dystrophy (2010) (0)
- Lentiviral haematopoietic stem cell gene therapy (HSC-GT) for metachromatic leukodystrophy (MLD): Preliminary results from a clinical trial with a cryopreserved formulation of OTL-200 (2019) (0)
- Feasibility and efficacy of high doses of antimetabolites followed by high-dose sequential chemoimmunotherapy (R-HDS) and autologous stem cell transplant (ASCT) in patients (pts) with systemic B-cell lymphoma (BCL) and central nervous system (CNS) involvement: A multicenter phase II trial. (2014) (0)
- Requirements for retroviral targeting of a suicide gene to alloreactive memory stem T cells for adoptive immunotherapy of leukemia (2008) (0)
- 3D Models of Surrogate Multiple Myeloma Bone Marrow Microenvironments: Insights on Disease Pathophysiology and Patient-Specific Response to Drugs (2021) (0)
- CO0001 MAVRILIMUMAB IMPROVES OUTCOMES IN SEVERE COVID-19 PNEUMONIA AND SYSTEMIC HYPER-INFLAMMATION (2020) (0)
- Biomarkers Predicting Acute GvHD and Transplant Outcomes in 120 Consecutive Allogeneic HSCT Recipients (2016) (0)
- Microvascular lung vessels obstructive thromboinflammatory syndrome in patients with COVID-19: Insights from lung intravascular optical coherence tomography (2023) (0)
- Artificial Intelligence Methods to Estimate Overall Mortality and Non-Relapse Mortality Following Allogeneic Hematopoietic Cell Transplantation in the Modern Era: An EBMT Transplant Complications Working Party Study (2022) (0)
- PS1061 ELDERLY PATIENTS WITH DE NOVO OR SECONDARY AML HAVE COMPARABLE OUTCOMES AFTER INTENSIVE TREATMENTS INCLUDING HIGH DOSE (HD) CYTARABINE AND AUTOLOGOUS (AUTO) OR ALLOGENEIC (ALLO) TRANSPLANTATION (SCT) (2019) (0)
- Hematopoietic Stem Cells Are Endowed with Erythroid Signature in Beta-Thalassemia (2020) (0)
- Infusions of HSV-TK genetically modified donor lymphocytes enable a wider use of partially mismatched allogeneic transplantation by reducing infection related mortality and improving survival in high risk acute leukemia. (2006) (0)
- Correction: Comparison of HLA-mismatched unrelated donor transplantation with post-transplant cyclophosphamide versus HLA-haploidentical transplantation in patients with active acute myeloid leukemia (2022) (0)
- CMV-Specific T Cells Restricted By Shared and Donor, but Not By Host HLA Molecules Reconstitute in the First 180 Days after Allogeneic HSCT and Protect from CMV Reactivation: Results of a Prospective Observational Study (2019) (0)
- Microrna-126 Levels Modulate B-ALL Aggressiveness but Require Tight Regulation to Guarantee Disease Maintenance (2018) (0)
- Cytotoxicity Is Not Required for the Anti-Leukemia Efficacy of Human H-Y-Specific CD4+ T Lymphocytes In Vivo. (2009) (0)
- ATIM-36. TEM-GBM-001 STUDY: AUTOLOGOUS CD34+ ENRICHED HEMATOPOIETIC PROGENITOR CELLS GENETICALLY MODIFIED FOR HUMAN INTERFERON-α2 & ADMINISTERED TO PATIENTS WITH GLIOBLASTOMA & AN UNMETHYLATED MGMT PROMOTER (2019) (0)
- Ex vivo hematopoietic stem cell gene therapy for mucopolysaccharidosis type I (Hurler syndrome) (2021) (0)
- State-ofthe-Art Paper Vox Sanguinis (2011) (0)
- availability transplantation : a retrospective study based on the time of HLA typing survival of Hodgkin lymphoma patients relapsing after autologous Allogeneic transplantation improves the overall and progression-free (2010) (0)
- Prediction of Nonrelapse Mortality in Patients With Acute Myeloid Leukemia and Acute Lymphoblastic Leukemia Receiving Allogeneic Stem Cell Transplantation With Posttransplantation Cyclophosphamide-based Graft Versus Host Disease Prophylaxis (2023) (0)
- PF227 PROGNOSTIC VALUE OF CLONAL HEMATOPOIESIS-MUTATIONS DETECTED AT DIAGNOSIS IN ACUTE MYELOID LEUKEMIA PATIENTS WITH NORMAL KARYOTYPE (2019) (0)
- BAT 2 and BAT 3 polymorphisms as novel genetic risk factors for rejection after HLA-related stem cell transplantation (2014) (0)
- Biffi Metachromatic Leukodystrophy Lentiviral Hematopoietic Stem Cell Gene Therapy Benefits (2013) (0)
- Minimal residual disease detection by next-generation sequencing in multiple myeloma: Promise and challenges for response-adapted therapy (2022) (0)
- S106: LONG-TERM FOLLOW-UP OF BETA-THALASSEMIA PATIENTS TREATED WITH HEMATOPOIETIC STEM CELL GENE THERAPY (2022) (0)
- 43-OR: Genomic loss of mismatched HLA in leukemia is a major mechanism of in vivo escape from T cell immunosurveillance following haploidentical hematopoietic stem cell transplantation (2009) (0)
- Immune Reconstitution Is a Predictive Biomarker of Chronic Graft-Versus-Host Disease: Analysis of 307 Consecutive Patients (2018) (0)
- Similar outcomes following non-first-degree and first-degree related donor haploidentical hematopoietic cell transplantation for acute leukemia patients in complete remission: a study from the Global Committee and the Acute Leukemia Working Party of the European Society for Blood and Marrow Transpla (2023) (0)
- Retroviral Vector Integration Deregulates Gene Expression but Has No Consequences on the Biology and Function of Transplanted T Cells. (2005) (0)
- Infusion of suicide gene-modified donor T cells promotes a rapid and effective immune reconstitution and provides long-term survival after haploidentical hemaopoietic cell transplantation for the cure of patients with high-risk leukemia (2008) (0)
- Second Solid Cancers After Hematopoietic Stem Cell Transplantation: Active Surveillance During Long-term Follow-up (2021) (0)
- Editorial: The latest advances in transplantation for AML (2023) (0)
- Reduced intensity conditioned allografts for myeloma : A study from the Chronic Leukaemia Working Party of the EBMT. (2002) (0)
- Graft-Versus-Host-Disease Prophylaxis with ATG or Ptcy in Patients with Lymphoproliferative Disorders Undergoing Reduced Intensity Conditioning Regimen 9/10 Mmud HCT (2022) (0)
- Bridging Chemotherapy: Adult Acute Lymphoblastic Leukaemia (2022) (0)
- CD19 Chimeric Antigen Receptor (CAR) T-Cell Therapy for Adults with B-Cell Acute Lymphoblastic Leukemia (B-ALL): A Large Real-World Series from Acute Leukemia Working Party of the European Society for Blood and Marrow Transplantation (EBMT) (2022) (0)
- The challenge of HSCs procurement for gene therapy of beta-Thalassemia : exploring plerixafor as mobilization agent (2013) (0)
- Rapid Molecular Detection of Pathogens in 516 Consecutive Haematological Patients with Febrile Neutropenia (2014) (0)
- Role of FDG-PET/CT in detecting relapse during follow-up of patients with Hodgkin’s lymphoma (2018) (0)
- Comparison of Fludarabine/Melphalan (FluMel) with Fludarabine/Melphalan/BCNU or Thiotepa (FBM/FTM) in Patients with AML in First Complete Remission Undergoing Allogeneic Hematopoietic Stem Cell Transplantation - a Registry Study on Behalf of the EBMT Acute Leukemia Working Party (2022) (0)
- Identification By Gene Expression Profiling Of CIITA-Dependent HLA Class II Transcriptional Downregulation As a Novel Mechanism Of Leukemia Immune Escape and Relapse After Allogeneic HSCT (2013) (0)
- R-CHOP Preceded By Engineered Tumor Necrosis Factor (TNF) in Patients with Relapsed or Refractory (r/r) Primary CNS Lymphoma (PCNSL): Results of Antitumor Activity, Safety and Blood-Brain Barrier (BBB) Permeabilization in the "Ingrid" Phase II Trial (2018) (0)
- Abstract 5213: Genetically modified Tie-2 expressing monocytes target IFN-α2 to the glioblastoma tumor microenvironment (TME): Preliminary data from the TEM-GBM Phase 1/2a study (2022) (0)
- PO-0915: Clinical Activation Of An Efficient Low-Dose Total Body Irradiation Using The Tomodirect Approach (2020) (0)
- 281. Engineering Hematopoiesis for Tumor-Targeted Interferon-alpha Delivery Inhibits Multuple Myeloma and B Cell Malignancies (2015) (0)
- Erratum: BAT2 and BAT3 polymorphisms as novel genetic risk factors for rejection after HLA-related SCT (Bone Marrow Transplantation (2014) 49 (1452) DOI:10.1038/bmt.2014.241) (2014) (0)
- Comparable Outcomes Following Non-First-Degree and First-Degree Related Donor Haploidentical Hematopoietic Cell Transplantation for Acute Leukemia Patients in Complete Remission: A Study from the Global Committee and the Acute Leukemia Working Party of the European Society for Blood and Marrow Trans (2022) (0)
- allogeneic stem-cell transplantation Antitumor effects of HSV-TKengineered donor lymphocytes after (2010) (0)
- The infusion of suicide gene-modified donor T cells after hematopoietic stem cell transplantation prompts thymic renewal in adult patients by an IL-7 dependent mechanism (169.4) (2011) (0)
- The Risk of Secondary Myelodysplastic Syndrome/Acute Leukemia Following Intensive Therapy and Autograft Correlates with the Type of Cells Grafted: A Survey on 1,347 Lymphoma Patients Receiving the High-Dose Sequential (HDS) Program. (2007) (0)
- Minnesota acute graft-versus-host disease risk score predicts survival at onset of graft-versus-host disease after post-transplant cyclophosphamide prophylaxis (2022) (0)
- Plerixafor single agent for autologous stem cells mobilization and collection in adult thalassemic patients : towards the assessment of the suitable hematopoietic stem cell Source for gene therapy of beta-thalassemia (2012) (0)
- Gas-exchange deficit and systemic hypoperfusion in COVID-19 and non-COVID-19 young adult patients with pneumonia. (2022) (0)
- Human Herpes Virus 6 Infection in 54 Patients after Allogeneic Hematopoietic Stem Cell Transplantation: Clinical Manifestations and Outcome (2014) (0)
- Intensive Treatment in Elderly AML Patients Induce Prolonged Survival and Disease Remission If Early Mortality Is Prevented: The Case Record of the San Raffaele Scientific Institute (2011) (0)
- Comparable survival for poor-risk cytogenetics AML in first complete remission after haploidentical donor or unrelated donor transplantation: a study from the ALWP of EBMT (2016) (0)
- 752. Single Chain TCR Gene Editing in Adoptive Cell Therapy for Multiple Myeloma (2016) (0)
- Arginine Deprivation Sustains Plasma Cell Fitness Via GCN2: A Novel Immuno-Metabolic Check-Point (2017) (0)
- Genomic and Transcriptional Immunoediting of Acute Myeloid Leukemia in Response to Allogeneic Hematopoietic Stem Cell Transplantation (2011) (0)
- Interaction Between Center Effect and Strategy for Graft Vs. Host Disease Prophylaxis on Outcome of T-Cell Depleted and T-Cell Replete Haploidentical Transplants, an Analysis on Behalf of ALWP-EBMT (2016) (0)
- Lentiviral Hematopoietic Stem and Progenitor Cell Gene Therapy for Metachromatic Leukodystrophy (MLD): Clinical Outcomes from 38 Patients (2021) (0)
- The Nurses Group Poster Session (2015) (0)
- Pilot Study to Assess Feasibility and Safety of Bone Marrow as Alternative Site in Islet Transplant Patients: 1 Year Follow-Up: 1891 (2012) (0)
- Topic: AS01-Diagnosis/AS01c-Molecular aberrations (cytogenetic, genetic, gene expression): A CARTOGRAPHY OF UBA1 GENE TESTING, EPIDEMIOLOGY AND CLINICAL-GENOMIC CHARACTERISTICS: THE VEXAS/MDS ITALIAN EXPERIENCE (2023) (0)
- Intrabone hematopoietic stem cell gene therapy for adult and pediatric patients affected by transfusion-dependent ß-thalassemia (2019) (0)
- 765. Suicide Gene Therapy by Central Memory Human T Lymphocytes (2006) (0)
- Measurable Residual Disease and Clonal Evolution in Acute Myeloid Leukemia from Diagnosis to Post-Transplant Follow-Up: The Role of Next-Generation Sequencing (2023) (0)
- S912 LOCAL INTERFERON-ALPHA DELIVERY INTO THE MYELOMA MICROENVIRONMENT BY GENE-ENGINEERED AUTOLOGOUS STEM CELL TRANSPLANTATION (2019) (0)
- Allogeneic Transplantation with a Treosulfan-Fludarabine Conditioning Regimen Is Feasible and Effective in Elderly Patients with Refractory or Relapsed Acute Myeloid Leukaemia (AML) and Myelodysplastic Syndrome (MDS); Preliminary Results From a Single Center Experience. (2009) (0)
- Short chemotherapy-phased imatinib (IM) pulses improve long-term outcome of adult patients with philadelphia chromosome-positive acute lymphoblastic leukemia (PH+ ALL) (2009) (0)
- Metabolomics identifies plasma biomarkers of multiple myeloma development and progression (2013) (0)
- Graft-versus-tumor effect following reduced-intensity allogeneic stem cell transplantation in prostate cancer. (2006) (0)
- Allogeneic hematopoietic stem cell transplantation (HSCT) in elderly patients with acute myeloid leukemia (AML) or myelodysplastic syndrome (MDS): A single center experience (2012) (0)
- Haploidentical Stem Cell Transplantation Attenuates the Prognostic Impact of FLT3-ITD in Acute Myeloid Leukemia (2017) (0)
- PS1268 CEFTAZIDIME/AVIBACTAM AND CEFTOLOZANE/TAZOBACTAM FOR THE TREATMENT OF FEBRILE NEUTROPENIA IN ALLOGENEIC TRANSPLANT RECIPIENTS (2019) (0)
- non-permissive mismatches for hematological stem cell transplantation A T cell epitope encoded by a subset of HLA-DPB1 alleles determines (2013) (0)
- S114 POST-TRANSPLANT CYCLOPHOSPHAMIDE VS ATG FOR GRAFT-VERSUS-HOST DISEASE PROPHYLAXIS IN T-REPLETE HAPLOIDENTICAL TRANSPLANTATION FOR ACUTE LYMPHOBLASTIC LEUKEMIA: A REPORT OF THE ALWP/EBMT (2019) (0)
- A Randomized Trial of Bone Marrow (BM) Versus Peripheral Blood (PB) Allogeneic Hemopoietic Stem Cell Transplants (HSCT) in Patients with Myeloproliferative Disorders. (2006) (0)
- A Case of Two Adult Brothers with Wiskott-Aldrich Syndrome, One Treated with Gene Therapy and One with HLA-Identical Hematopoietic Stem Cell Transplantation (2021) (0)
- Multicenter Phase II Trial Addressing Lenalidomide Maintenance in Patients with Relapsed Diffuse Large B-Cell Lymphoma (rDLBCL) Who Are Not Eligible for Autologous Stem Cell Transplantation (ASCT): Efficacy and Safety Results after a Median Follow-up of Five Years (2018) (0)
- Allogeneic Hematopoietic Stem Cell Transplantation (HSCT) in Patients with Therapy-Related Myeloid Neoplasm: A Study from the Chronic Malignancies Working Party of the EBMT. (2019) (0)
- Stem Cell-Based Therapies, Remyelination, and Repair Promotion in the Treatment of Multiple Sclerosis (2016) (0)
- Graft-versus-lymphoma effect inside the central nervous system in a patient with extranodal natural killer/T-cell lymphoma, nasal type. (2021) (0)
- High Alloreactive Potential of Central Memory T-Lymphocytes Expressing a Suicide Gene for the Cure of Hematologic Malignancies. (2006) (0)
- ESTABLISHING A NATIONAL NETWORK OF LABORATORIES USING NEXT GENERATION AMPLICON DEEP SEQUENCING FOR BCR-ABL1 KINASE DOMAIN MUTATION SCREENING: THE 'NEXT-IN-CML' STUDY (2017) (0)
- Permissive HLA-DPB1 Mismatch and Survival after Unrelated Donor Allogeneic Stem Cell Transplantation for Hematological Malignancies: A Comparative Analysis of Different Immunogenetic Models on 422 Patients from GITMO and IBMDR (2018) (0)
- Publisher Correction: Viral clearance after early corticosteroid treatment in patients with moderate or severe covid-19 (2021) (0)
- Improved outcomes over time and higher mortality in CMV seropositive allogeneic stem cell transplantation patients with COVID-19; An infectious disease working party study from the European Society for Blood and Marrow Transplantation registry (2023) (0)
- Diagnosis and severity criteria for sinusoidal obstruction syndrome/veno-occlusive disease in adult patients: a refined classification from the European society for blood and marrow transplantation (EBMT). (2023) (0)
- Second Allogeneic Stem Cell Transplantation (allo-SCT) Using Reduced-Intensity Conditioning (RIC) for Acute Myeloid Leukemia (AML) Patients Who Relapsed Following a First RIC Allo-SCT: a Survey From the Acute Leukemia Working Party of EBMT. (2010) (0)
- Loss of Mismatched HLA At Leukemia Relapse After Hematopoietic Stem Cell Transplantation Is Significantly Associated with Clinical and Immunogenetic Hallmarks of Donor-Versus-Host Alloreactivity (2012) (0)
- Matched related versus unrelated versus haploidentical donors for allogeneic transplantation in AML patients achieving first complete remission after two induction courses: a study from the ALWP/EBMT. (2022) (0)
- Validation of the Cibmtr Score in Predicting the Outcome of Hematopoietic Stem-Cell Transplantation in AML Patients Not in Complete Remission At the Time of Conditioning: A Retrospective Analysis On Behalf of the Gruppo Italiano Trapianto Di Midollo Osseo (GITMO) (2012) (0)
- The Disease-Risk Stratification Scheme (DRSS), a Contemporary Risk-Stratification System for Allogeneic Stem Cell Transplantation. (2019) (0)
- ALLOGENEIC STEM CELL TRANSPLANTATION FOLLOWING A REDUCED INTENSITY CONDITIONING REGIMEN IN RELAPSED PERIPHERAL T-CELL LYMPHOMAS (PTCL): RESULTS AFTER A MEDIAN FOLLOW-UP OF 67 MONTHS (2011) (0)
- Human Herpes Virus-6 and Clinical Manifestations After Allogeneic Hematopoietic Stem Cell Transplantation (2011) (0)
- In Adult Acute Lymphoblastic Leukemia End of Induction MRD Correlates Strongly with Subsequent Key Timepoints and Predicts Long Term Outcome (2017) (0)
- microRNA-126 Orchestrates a Stem Cell-like Program in AML and B-ALL and Can be Exploited to Dissect Disease Heterogeneity (2016) (0)
- Allogeneic Stem Cell Transplantation in Patients with Myelodysplastic Syndrome (MDS) Using Treosulfan Based Compared to Standard Reduced-Intensity or Myeloablative Conditioning Regimens. a Report of the Chronic Malignancies Working Party of EBMT (2020) (0)
- The 44th Annual Meeting of the European Society for Blood and Marrow Transplantation: Physicians Award Winners (2018) (0)
- Early and Profound Exhausted Phenotype of Central Memory and Memory Stem T Cells in the Bone Marrow of AML Patients Characterizes and Predicts Relapse after Allo-HSCT (2017) (0)
- Reprogramming Macrophages Using Autologous Hematopoietic Stem Cells As Immunotherapy for Glioblastoma: TEM-GBM Study (NCT03866109) (2022) (0)
- Post-Transplant Cyclophosphamide in Acute Leukemia Patients Receiving More Than 5/10 HLA-Mismatched Allogeneic Stem Cell Transplantation: A Study on Behalf of the ALWP of the EBMT (2021) (0)
- Total marrow irradiation (TMI) combined with treosulfan and fludarabine conditioning regimen for chemosensitive advanced multiple myeloma (MM) patients undergoing matched allogeneic stem-cell transplantation: First results of a phase I/II prospective monocentric study (TrRaMM TMI). (2018) (0)
- Prolonged Survival of Lymphoma Patients Achieving Complete Remission Following High-Dose Sequential Chemotherapy and Autograft (HDS Program): A GITIL (Gruppo Italiano Terapie Innovative Nei Linfomi) Retrospective Study on 1,266 Patients. (2006) (0)
- Monitoring for virus-specific T-cell responses and viremia in allogeneic HSCT recipients: a survey from the EBMT Cellular Therapy & Immunobiology Working Party (2023) (0)
- Clinical Relevance of MYD88 L265P Mutation and Interleukin-10 Level in Cerebrospinal Fluid of Patients with Both Newly Diagnosed and Relapsed Primary Diffuse Large B-Cell Lymphoma of the Central Nervous System (2019) (0)
- Allogeneic Stem Cell Transplantation from Haploidentical Versus Matched Sibling Donors for Adult Patients with Relapsed/Refractory Acute Lymphoblastic Leukemia: A Study from the Acute Leukemia Working Party of the European Society for Blood and Marrow Transplantation (2022) (0)
- Favourable Outcome after Treosulfan Based Conditioning of Patients Receiving an Allogeneic Hematopoietic Cell Transplantation (AlloHCT) for the Treatment of a Myelodysplastic Syndrome (MDS) (2022) (0)
- Label-free characterization of extracellular vesicles from human Mesenchymal Stem Cells by Raman spectroscopy (2015) (0)
- Clonal tracking of engineered human hematopoiesis through integration sites analysis (2016) (0)
- Inhibitor of DNA binding 2 (ID2) regulates key transcriptional programs in multiple myeloma (2019) (0)
- Continuously Improving Outcome over Time after Second Allogeneic Stem Cell Transplantation in Relapsed Acute Myeloid Leukemia - a Retrospective Analysis of 1540 Patients on Behalf of the Acute Leukemia Working Party of EBMT (2022) (0)
- Antifungal Prophylaxis with Posaconazole in Allogeneic Hematopoietic Stem Cell Transplantation Using Sirolimus for Prevention of Graft-Versus-Host Disease (2015) (0)
- The 'Next-in-Cml' Study: A Prospective Multicenter Study of Deep Sequencing of the BCR-ABL1 Kinase Domain in Philadelphia Chromosome-Positive Patients with Non-Optimal Responses to Tyrosine Kinase Inhibitor Therapy (2016) (0)
- Posttransplant cyclophosphamide‐based anti–graft‐vs‐host disease prophylaxis in patients with acute lymphoblastic leukemia treated in complete remission with allogeneic hematopoietic cell transplantation from human leukocyte antigen‐mismatched unrelated donors versus haploidentical donors: A study o (2022) (0)
- Validation of the Transplant Conditioning Intensity (TCI) Score for Allogeneic Hematopoietic Cell Transplantation (2022) (0)
- stem cell transplantation depleted - for early immune reconstitution after hematopoietic T-cell Immunologic potential of donor lymphocytes expressing a suicide gene (2013) (0)
- Natural Killer Cell Reconstitution after Haploidentical Hematopoietic Stem Cell Transplantation with Post-Transplant Cyclophosphamide: Elimination of Donor-Derived Mature Alloreactive NK Cells, but Favorable Conditions for Adoptive Immunotherapy (2016) (0)
- Haploidentical Transplantation Outcomes for Secondary Acute Myeloid Leukemia—on Behalf of the ALWP of the EBMT (2018) (0)
- A survey on preoperative autologous blood donation policy in bone marrow stem cell donors in Italy. (2022) (0)
- Thymic Renewal and Anti-Leukemic Effect In Adults After Haploidentical Transplantation and Donor T Cell Suicide Gene Therapy (2010) (0)
- Gene transfer in Naive-derived memory stem T-cells: a novel promising platform for cancer immunotherapy (2012) (0)
- 209. TCR Gene Editing in a Single Step of T Cell Activation To Redirect T Cell Specificity and Prevent GvHD (2015) (0)
- Unmanipulated Graft Transplantation From Family Haploidentical Donors: A Survey On 183 Adult Patients with Acute Leukemias On Behalf of the Acute Leukemia Working Party of the European Group for Blood and Marrow Transplantation (EBMT) (2012) (0)
- Haploidentical Versus Autologous Stem Cell Transplantation in Adult Acute Leukemia: A Matched Pair Analysis from the Acute Leukemia Working Party of the European Society for Blood and Marrow Transplantation (EBMT) (2014) (0)
- Longitudinal Tracking of Acute Myeloid Leukemia Stem Cells in Xenografts and Patients By microRNA Reporters and Single Cell RNA Sequencing (2019) (0)
- On-Board Traffic Management (1998) (0)
- Comparison of outcome after haplo-identical, HLA-mismatched unrelated donor and unrelated cord blood transplantation in patients with myelodysplastic syndrome (MDS) and secondary acute myeloblastic leukemia (sAML): an EBMT study (2016) (0)
- Editorial: Novel Immunological Biomarkers for Allogeneic HSCT Outcome (2021) (0)
- Autologous hematopotoietic stem cell transplantation in multiple sclerosis with an intermediate intensity conditioning regimen : the Italian multi-centre experience (2011) (0)
- Poster group 2 – Haemopoietic stem cell transplantation (2004) (0)
- TRANSPLANTATION Outcome of patients with distinct molecular genotypes and cytogenetically normal AML after allogeneic transplantation Group of Bone Transplantation (2015) (0)
- Long-Term Immunological Profile and T Cell Dynamics In Patients Treated With Allogeneic Transplantation and TK-Cells For Hematological Malignancies (2013) (0)
- A Novel Assay in Whole Blood Demonstrates Restoration of Mitochondrial Activity in Phagocytes After Successful HSCT in Hyperinflamed X-Linked Chronic Granulomatous Disease (2022) (0)
- A274 Long-Term Outcome After Allogeneic Hematopoietic Stem Cell Transplantation in Multiple Myeloma (2009) (0)
- LONG‐TERM EFFICACY AND SAFETY OF LENALIDOMIDE MAINTENANCE IN PATIENTS WITH RELAPSED DIFFUSE LARGE B‐CELL LYMPHOMA WHO ARE NOT ELIGIBLE FOR AUTOLOGOUS TRANSPLANTATION (ASCT) (2019) (0)
- Minimal Residual Disease (MRD)-Oriented Therapy of Adult Acute Lymphoblastic Leukemia (ALL): Final Results of Northern Italy Leukemia Group Study 09/00. (2007) (0)
- High Risk of Secondary Infections Following Thrombotic Complications in Patients With COVID-19 (2022) (0)
- 780 POTENTIAL RELATIONSHIP BETWEEN MITOCHONDRIAL FERRITIN EXPRESSION AND CARDIOTOXICITY IN PATIENTS UNDERGOING ANTHRACYLINE CHEMOTHERAPY (2022) (0)
- Bone Marrow Transplantation for Immune Therapy (2003) (0)
- First-in-human phase I/II clinical trial of hematopoietic stem and progenitor cell gene therapy for Hurler syndrome: Favorable safety profile and extensive metabolic correction (2022) (0)
- PS1437 SETD2 NON-GENOMIC LOSS OF FUNCTION IN ADVANCED SYSTEMIC MASTOCYTOSIS (SM): PATHOGENETIC AND THERAPEUTIC IMPLICATIONS (2019) (0)
- Pre-engraftment neurological impairment in allogeneic stem cell transplant: A case report of atypical posterior reversible encephalopathy syndrome with pontine involvement (2023) (0)
- Second Allogeneic Stem Cell Transplantation (AlloSCT) In Patients With Relapsed Lymphoma After First Allosct. A Retrospective Study Of The EBMT Lymphoma Working Party (2013) (0)
- Impact of measurable residual disease on outcomes of unrelated donor haematopoietic cell transplantation with post-transplant cyclophosphamide in AML in first complete remission. (2023) (0)
- Editing Human Lymphocyte Specificity for Safe and Effective Adoptive Immunotherapy of Leukemia. (2010) (0)
- Personalized Risk-Profiling for Acute Leukemia Patients Undergoing Haploidentical Allogeneic Hematopoietic Stem Cell Transplantation: A Study on Behalf of the Acute Leukemia Working Party of the EBMT (2020) (0)
- Allogeneic Stem Cell Transplantation in Myelodysplastic Syndrome; A More Favorable Outcome after Fludarabine and Treosulfan Conditioning. a Survey on Behalf of the Chronic Malignancies Working Party of the EBMT (2014) (0)
- Effect of HLA-Matching on Outcome of Hematopoietic Stem Cell Transplantation from Unrelated Donors: A IBMDR-GITMO Study. (2007) (0)
- Autologous Hematopoietic Stem Cell Transplantation In Neuromyelitis Optica: A Retrospective Study Of The EBMT Autoimmune Diseases Working Party In Collaboration With The University Of Sao Paulo, Ribeirao Preto, Brazil (2013) (0)
- Quantitative Real-Time PCR Detection of Wilms' Tumor Gene (WT1) Transcript in Autologous Peripheral Blood Stem Cell (PBSC) Products Predict the Risk of Acute Myeloid Leukaemia (AML) Relapse After Autologous Transplantation (ASCT). (2009) (0)
- A Novel t(5;7)(q31;q21)/CDK6::IL3 in Immature T-cell Acute Lymphoblastic Leukemia With IL3 Expression and Eosinophilia (2022) (0)
- 7129 Long-term follow-up of metastatic renal cancer patients undergoing HLA-identical reduced-intensity allografting (2009) (0)
- COEFFICIENT OF RESTITUTION / LEEB REBOUND HARDNESS FOR SIX METEORITES AND HCCL-1 SIMULANT (2021) (0)
- RUNNING TITLE: Bone marrow and pancreatic islet (2013) (0)
- Clofarabine Containing Conditioning Regimen for Allo-SCT in AML/ALL Patients: A Survey From the Acute Leukemia Working Party of EBMT (2011) (0)
- Immune Suppression By High-Density Neutrophils Predicts Short Progression-Free Survival in Multiple Myeloma (2016) (0)
- Impact of donor kinship on non-T-cell depleted haploidentical stem cell transplantation with post transplantation cyclophosphamide for acute leukemia: From the ALWP of the EBMT (2022) (0)
- Abstract CT312: Ponatinib is well tolerated and active in patients with relapsed/refractory philadelphia positive leukemias: The Bologna experience (2014) (0)
- 637. Targeting of Myeloid Leukemia by IL-10-Engineered Human CD4+ Tr1 Cells (2016) (0)
- Full Dose Treosulfan Based Reduced Toxicity Conditioning Regimen in Allogeneic Stem Cell Transplantation: Results in 123 Patients. (2012) (0)
- Intensive treatment of elderly patients with acute myeloid leukemia or myelodysplastic syndrome: a single center experience (2008) (0)
- Electron microscopy and functional studies reveal cellular stress in amyloidogenic plasma cells (2013) (0)
- Parent-Child Perceptions of Health-Related Quality of Life in Pediatric Patients with Beta-Thalassemia (2012) (0)
- Outcome of SARS-CoV2 infection in hematopoietic stem cell transplant recipients for autoimmune diseases (2023) (0)
- Non-T-Cell Depleted Haploidentical Stem Cell Transplantation (haploHCT) with Post Transplantation Cyclophosphamide (PTCy)- the Role of Donor Kinship: From the ALWP of the EBMT (2021) (0)
- Primary Cancer Matters in Therapy-related Myeloid Neoplasm Patients Receiving Allogeneic Hematopoietic Cell Transplantation: A Study From the Chronic Malignancies Working Party of the EBMT (2023) (0)
- Early immune reconstitution and abrogation of GvHD after infusion of HSV-TK engineered donor lymphocytes after haplo-identical hemopoietic stem cell transplantation. (2004) (0)
- An Accelerated CD8+, but Not CD4+, T-Cell Reconstitution Associates with a More Favorable Outcome Following HLA-Haploidentical HSCT: Results from a Retrospective Study of the Cell Therapy and Immunobiology Working Party of the EBMT (2015) (0)
- ABO Mismatching and Haploidentical Hematopoietic Stem Cell Transplantation in Acute Myeloid Leukemia—a Report from the ALWP of the EBMT (2017) (0)
- High Resolution Donor/Recipient HLA Matching Level in Unrelated Hematopoietic Stem Cell Transplantation and Impact on the Transplant Outcome: The Italian Experience on Behalf of GITMO, IBMDR and Aibt (2018) (0)
- IMMU-01. TEM-GBM: AN OPEN-LABEL, PHASE I/IIA DOSE-ESCALATION STUDY EVALUATING THE SAFETY AND EFFICACY OF GENETICALLY MODIFIED TIE-2 EXPRESSING MONOCYTES TO DELIVER IFN-A WITHIN GLIOBLASTOMA TUMOR MICROENVIRONMENT (2021) (0)
- Health-related quality of life in pediatric patients with beta-thalassemia according to child and parent reports (2011) (0)
- IL-7 receptor expression identifies suicide gene–modified allospecific CD8 (cid:1) T cells capable of self-renewal and differentiation into antileukemia effectors (2011) (0)
- Facing the Rising Tide of Multidrug Resistant Gram-Negative Pathogens in Allogeneic HSCT with Nanosphere's Verigene® System (2015) (0)
- miR-126 Regulates Distinc t Self-Renewal Outcomes in Normal and Malignant Hematopoietic Stem Cells Graphical (0)
- Prediction of Leukemia-Free Survival Following Haploidentical Stem Cell Transplantation in Acute Myeloid Leukemia: A Study from the Acute Leukemia Working Party of the EBMT (2018) (0)
- Generation of Memory Stem T Cells Specific for Tumor Antigens and Resistant to Inhibitory Signals By Genome Editing (2018) (0)
- Treosulfan-Based Myeloablative Conditioning for Autologous Stem Cell Transplantation In Elderly Patients with Acute Myeloid Leukemia or Myelodysplastic Syndrome: Data of Feasibility and Efficacy In 10 Patients. (2010) (0)
- Mechanism of thymic renewal after infusion of suicide gene-modified donor T cells after hematopoietic stem cell transplantation (HSCT) in adult patients. (2011) (0)
- Identification and characterization of Aspergillus-specific immune responses to diagnose invasive aspergillosis in high risk patients: a multicenter study (2011) (0)
- Inverse correlation between central hypogonadism and circulating IL-10 levels in males with severe COVID-19 (2021) (0)
- Leukemic Blasts Secondary to Myelodysplastic Syndromes Are Molecularly Programmed To Differentiate into Functionally Mature Dendritic Cells. (2007) (0)
- Haploidentical Transplantation Outcome is Not Inferior to Standard Matched Related - Unrelated Donor Transplantation: An Intention-to-Treat Analysis of 611 Patients in 8-Years Experience at San Raffaele Scientific Institute (2013) (0)
- Update on safety and efficacy of lentiviral hematopoietic stem cell gene therapy (HSC-GT) for metachromatic leukodystrophy (MLD) (2017) (0)
- Abstract CT180: Changes in immunologic responses and in the tumor microenvironment in patients with glioblastoma multiforme treated with IFN-a immune cell and gene therapy (TEM-GBM_001 Study) (2021) (0)
- HHV6 Specific T-Cells Are Predictive Biomarker of Active HHV6 Infection after Allogeneic Hematopoietic Stem Cell Transplantation: Results of a Prospective Study in 213 Patients (2016) (0)
- Backtracking Leukemia Clonal Evolution from Post-Transplantation Relapse to Initial Diagnosis to Identify Founder Mutations and Mechanisms of Immune Evasion (2014) (0)
- Longitudinal Microbiome Profile in Allogeneic Hematopoietic Stem Cell Transplantation: Results of a Prospective Study in 100 Patients (2016) (0)
- Impaired GvL Potential of Natural Killer Cells Early Reconstituting Following Haploidentical HSCT. (2006) (0)
- Azacitidine and donor lymphocytes infusions in acute myeloid leukemia and myelodysplastic syndrome relapsed after allogeneic hematopoietic stem cell transplantation from alternative donors (2022) (0)
- Requirements for Retroviral Targeting of a Suicide Gene to Alloreactive Memory Stem T Cells for Adoptive Immunotherapy of Leukemia. (2007) (0)
- Conditioning Regimen Intensity and Donor Choice Do Not Impact Outcomes of Patients (pts) with Acute Myeloid Leukemia (AML) after Allogeneic Hematopoietic Cell Transplantation (Allo-HCT) in First Complete Remission (CR1): An EBMT Analysis (2022) (0)
- Correction to: Impact of conditioning regimen intensity on outcomes of second allogeneic hematopoietic cell transplantation for secondary acute myelogenous leukemia (2022) (0)
- Risk Factors Influencing Transplant Outcomes of Adults with Acute Lymphoblastic Leukemia in First Complete Remission: A Retrospective Analysis from the ALWP of the EBMT (2022) (0)
- Longitudinal single-cell profiling of chemotherapy response in acute myeloid leukemia (2023) (0)
- An Overview of the Prophylaxis and Treatment of GvHD in Haploidentical SCT (2017) (0)
- Modeling leukemia immunoediting in mouse-human chimeras (P2169) (2013) (0)
- Impact of gemtuzumab ozogamicin consolidation on hematopoietic stem cells (HSCs) mobilization in AML: analysis of 20 patients (2023) (0)
- post-transplant Cyclophosphamide Eliminates Mature Donor Nk Cells Infused with the Graft, Dampening Nk Cell Alloreactivity after Haploidentical Hsct : p078 (2016) (0)
- Haploidentical Versus Matched Sibling Donor Hematopoietic Stem Cell Transplantation for Adult Patients With Relapsed/Refractory Acute Lymphoblastic Leukemia: A Study From the Acute Leukemia Working Party of the European Society for Blood and Marrow Transplantation (2021) (0)
- Case report: Ponatinib as a bridge to CAR-T cells and subsequent maintenance in a patient with relapsed/refractory Philadelphia-like acute lymphoblastic leukemia (2023) (0)
- Characteristics of a Well Recorded, Bright, Meteorite-Dropping Fireball, British Columbia, Canada, September 4, 2017 (2018) (0)
- Secondary SOLID Tumors after Allogeneic STEM CELL Transplantation: A CROSS-Sectional Evaluation in 260 Adults at 1-Year Follow-up (2016) (0)
- Impacts and Evaluations of a Software Reuse Methodology for Onboard Component Development (1996) (0)
- Molecular Follow-Up of Patients Treated with HSV-TK/ΔLNGFR Engineered Donor Lymphocytes after Allogeneic Stem Cell Transplantation. (2004) (0)
- Chemotherapy Dose Adjustment For Obese Patients Undergoing Hematopoietic Stem Cell Transplantation (HSCT): A Survey On Behalf Of The ALWP Of The EBMT (2013) (0)
- Availability of HLA-allele-matched unrelated donors and registry size: Estimation from haplotype frequency in the Italian population. (2021) (0)
- PERIPHERAL PEAK RINGS ON MERCURY AND IMPLICATIONS FOR NEAR SURFACE GEOLOGY AND ANALYSIS OF CRATER POPULATIONS (2018) (0)
- Low-Dose Antithymocyte Globulin, Post-Transplant Cyclophosphamide and Sirolimus As Graft-Versus-Host Disease Prophylaxis in Unrelated Donor Transplants (2015) (0)
- NEXT GENERATION SEQUENCING (NGS) CONFIRMED THE ADVERSE CLINICAL IMPACT OF RUNX1 MUTATIONS IN A SUBSET OF ACUTE MYELOID LEUKEMIA NORMAL KARYOTYPE PATIENTS NEGATIVE FOR RISK DEFINING GENES MUTATIONS AND HOMOGENOUSLY TREATED WITHIN A CLINICAL TRIAL (NILG AML 02/06) (2017) (0)
- CD3+ Graft Cell Count Predicts Chronic Gvhd Incidence in Haploidentical Allogeneic Transplantation Using Post-Transplant Cyclophosphamide (2018) (0)
- Integrated use of tumor AI volumetrics and advanced MRI to assess early response to Temferon in a phase 2 GBM trial: A novel paradigm. (2021) (0)
- The 46th annual meeting of the European society for blood and marrow transplantation: nurses group oral session (NO001-NO015) (2020) (0)
- Busulfan or Treosulfan Conditioning Platform for Allogeneic Stem Cell Transplantation in Patients Aged >60 Y With Acute Myeloid Leukemia/Myelodysplastic Syndrome: A Subanalysis of the GITMO AlloEld Study (2023) (0)
- from naive precursors IL-7 and IL-15 instruct the generation of human memory stem T cells (2013) (0)
- Autologous and Allogeneic Stem Cell Transplantation for Richter's Transformation: A Retrospective Analysis From the Chronic Leukaemia Working Party and Lymphoma Working Party of the EBMT. (2009) (0)
- Imaging biomarkers of leukaemic choroidopathy. (2023) (0)
- Extreme Heterogeneity Of Myeloablative Total Body Irradiation (TBI) Techniques Across Europe: A Survey Of Acute Leukemia Working Party Of The EBMT (2013) (0)
- Effect of Related and Unrelated Donor Haemopoietic Stem-Cell Transplantation on Outcome In Adults with High Risk Acute Leukemia: An Intention-to-Treat Analysis at a Single Center Institution (2010) (0)
- Hematopoietic cell transplantation and cellular therapies in Europe 2021. The second year of the SARS-CoV-2 pandemic. A Report from the EBMT Activity Survey (2023) (0)
- Association of Donor-Recipient HLA Matching with Outcome of Unrelated Donor Hematopoietic Stem Cell Transplantation: A Study from the Cellular Therapy and Immunobiology Working Party (CTIWP) of the European Society for Blood and Marrow Transplantation (EBMT) (2019) (0)
- Efficacy of Fludarabine and Cytarabine Combination for Salvage Treatment of Refractory/Relapsed Myelodysplastic Syndrome (MDS) and Acute Myeloid Leukemia (AML): Promising Results from a Single Center Experience. (2005) (0)
- Comparison of Matched Sibling, Unrelated and Haploidentical Donor Transplants Using Post-Transplant Cyclophosphamide in Patients with Acute Myeloid Leukemia, a Study of the ALWP EBMT (2020) (0)
- Bone-to-Bone Stem Cell Infusion In Graft Failure After Haploidentical Hematopoietic Stem Cell Transplantation: Safety and Feasibility. Three Case Report (2010) (0)
- Human mesoangioblasts can elicit alloreactive T-cell immune responses: implications for allogeneic cell therapy of DMD (2012) (0)
- Receptor Repertoire Reconstitution Suggests Acquisition of Patient-Specific Tolerance by Natural Killer Cells Arising from Hematopoietic Progenitor Stem Cells after Haploidentical Transplantation. (2005) (0)
- Risk Factors for Outcomes of Family Haploidentical Allogeneic Stem Cell Transplantation for Adults with Acute Leukemias: A Survey on Behalf of the Acute Leukemia Working Party of the European Group for Blood and Marrow Transplantation (EBMT). (2004) (0)
- TK-Cells Safety and Efficacy in Allogeneic Hematopoietic Stem Cell Transplantation: Long-Term Clinical and Molecular Assessment in 128 Treated Patients. (2012) (0)
- Significance of Degree of HLA Disparity When Using Haploidentical Donors with T-Replete PBSC and Post-Transplantation Cyclophosphamide (PTCy) in Acute Myeloid Leukemia (AML) in First Complete Hematologic Remission (CR1) (2021) (0)
- Graft-versus-Host Disease Prophylaxis with Post-Transplantation Cyclophosphamide versus Cyclosporine A and Methotrexate in Matched Sibling Donor Transplantation Transplantation and Cellular Therapy (2022) (0)
- The Challenge Of HSCs Procurement For Gene Therapy: Exploring Plerixafor As Mobilization Agent (2013) (0)
- Haploidentical Mismatched Allogeneic Versus Autologous Hematopoietic STEM CELL Transplantation in Adult Patients with ACUTE Myeloid Leukemia (AML) in First Complete Remission (CR1): A Pair-Matched Analysis From the Acute Leukemia Working Party of EBMT. (2012) (0)
- P1371: GRAFT-VERSUS-HOST DISEASE OFFERS NO GRAFT-VERSUS-LEUKEMIA ADVANTAGE IN PATIENTS WITH ACUTE LYMPHOBLASTIC LEUKEMIA AFTER HAPLO-IDENTICAL STEM CELL TRANSPLANTATION WITH POST-TRANSPLANT CYCLOPHOSPHAMIDE (2022) (0)
- Impact of Conditioning Regimen on Outcomes of T-Replete Haplo-Identical Transplantation for Patients Over 45 Years-Old with AML: A Study On Behalf Of the Acute Leukemia Working Party of the EBMT (2017) (0)
- Post-transplant cyclophosphamide and sirolimus based graft-versus-host disease prophylaxis after allogeneic stem cell transplantation for acute myeloid leukemia (2022) (0)
- Haploidentical Hematopoietic Stem Cell Transplantation with Treosulfan-Based Conditioning Regimen for Acute Leukemia Relapsing after Initial Allogeneic Transplantation (2014) (0)
- Intrinsic Molecular Features of Human Hematopoietic Stem Cells from Different Sources Define Their Specific Functional Properties (2015) (0)
- Evaluation of NIH-Defined Chronic Graft-Versus-Host-Disease in a Rapamycin-Based Haploidentical Stem Cell Transplantation: Analysis of 113 Consecutive Patients with High Risk Haematological Malignancies (2012) (0)
- Exploring limiting factors in the prediction of allogeneic HSCT related mortality: an in-silico machine learning analysis of the acute leukemia working party (ALWP) registry of the EBMT (2015) (0)
- Conditioning Intensity In Middle Aged Patients With AML In CR1. No Advantage For Myeloablative Regimens Irrespective Of The Risk Group. An Observational Analysis By The Acute Leukemia Working Party Of The EBMT (2013) (0)
- PF751 POST-TRANSPLANT CYCLOPHOSPHAMIDE AND SIROLIMUS IN HAPLOIDENTICAL TRANSPLANT WITH PBSC GRAFTS: RESULTS IN 151 PATIENTS (2019) (0)
- Retrospective comparison of transplant from matched unrelated donor or identical sibling in adult MDS : evidence for a graft-versus-myelodysplasia effect in unrelated donor transplant (2007) (0)
- Escalated Dose-Rates of Total Marrow Irradiation (TMI) Combined with Treosulfan and Fludarabine-Based Conditioning Chemotherapy Regimen for Chemosensitive Advanced Multiple Myeloma (MM) Patients Undergoing a Matched Allogeneic Stem-Cell Transplantation: First Results of a Phase I/II Prospective Mono (2016) (0)
- 505. Impact of Remdesivir on SARS-CoV-2 Clearance in a Real-Life Setting: A Matched-Cohort Study (2021) (0)
- Minnesota acute GvHD risk score predicts survival at onset of GvHD after PTCy prophylaxis. (2022) (0)
- Leukemic Dendritic Cells Expand Central Memory T Lymphocytes From HCT Donors Able to React against the Original Leukemia in Vitro and In Vivo. (2009) (0)
- Autologous haematopoietic stem cell transplantation is more effective in relapsing/remitting multiple sclerosis forms (2009) (0)
- Use of Post-Transplant Cyclophosphamide in One-Antigen Mismatched Unrelated Donor Transplantation Results in Similar Transplant Outcomes Than Haploidentical Hransplantation: A Retrospective Study on Behalf of the Acute Leukemia Working Party of the EBMT (2020) (0)
- HLA disparities on unshared haplotype influence outcomes of unmanipulated haploidentical hematopoietic stem cell transplantation (HaploSCT): A Study from the Acute Leukemia Working Party of European Society for Blood and Marrow Transplantation (EBMT) (2016) (0)
- Chapter 10 – Haploidentical Transplantation (2017) (0)
- A New Clinico-Biological Scoring System for the Prediction of after Hematopoietic Stem (2017) (0)
- Physicians Abstracts (2015) (0)
- Mesoangioblasts at 20: From the embryonic aorta to the patient bed (2023) (0)
- Characteristics, treatment, outcomes and cause of death of invasively ventilated patients with COVID-19 ARDS in Milan, Italy. (2020) (0)
- NY-ESO-1 Single Edited T Cells to Treat Multiple Myeloma without Inducing GvHD (2014) (0)
- Impact of Fourth Methotrexate Dose in ATG-Cyclosporine GvHD Prophylaxis in HLA-Matched Unrelated HSCT: A GITMO Study (2022) (0)
- Randomized phase III trial of haploidentical HCT with or without an add back strategy of HSV-TK donor lymphocytes in patients with high-risk acute leukemia. (2012) (0)
- Ibrutinib Alone or in Combination with R-CHOP Chemoimmunotherapy in Relapsed or Refractory Primary Central Nervous System Lymphoma (rrPCNSL): A «Real-Life» Study (2022) (0)
- P156 Allogeneic stem cell transplantation in patients with poor prognosis myelodysplastic syndrome (MDS) or secondary acute myeloid leukaemia (sAML): results from a single centre experience (2007) (0)
- Factors Predicting Outcome after Allogeneic Stem Cell Transplantation in Primary Refractory Acute Myeloid Leukemia: A Retrospective Analysis of the Gruppo Italiano Trapianto Di Midollo Osseo (GITMO) (2014) (0)
- Intensification Of Treosulfan and Fludarabine-Based Conditioning With 4 Gy TBI For Allogeneic Stem Cell Transplantation In Patients With Hematological Malignancies (2013) (0)
- Human Herpes Virus 6 Reactivation and Disease After Allogeneic Hematopoietic Stem Cell Transplantation (2013) (0)
- Haploidentical Peripheral Blood Stem Cell Transplantation after Treosulfan-Based Conditioning and Rapamycin GvHD Prophylaxis in Hodgkin Lymphoma (2016) (0)
- P05.02 A phase I/IIa dose escalation study evaluating the safety and efficacy of autologous CD34+ enriched hematopoietic progenitor cells genetically modified for human interferon-α2 in patients with GBM and an unmethylated MGMT promoter (TEM-GBM-001) (2019) (0)
- Tumour-derived PGD2 and NKp30-B7H6 engagement drives an immunosuppressive ILC2-MDSC axis (2017) (0)
- Haploidentical Allogeneic Stem Cell Transplantation in Poor Risk Cytogenetic Acute Myeloide Leukemia: Results in 33 Patients (2014) (0)
- Evaluating CD8+ Memory Stem T Cells Dynamics After Allogeneic Bone Marrow Transplantation: Impact On GvHD Occurrence (2012) (0)
- WT1 Transcripts Is a Powerful Leukemia Marker to Predict Early Relapse After Allogeneic Haematopoietic Stem Cell Transplantation. (2009) (0)
- Review for "Evidence of long-lasting anti-CD19 activity of engrafted CD19 chimeric antigen receptor-modified T cells in a phase I study targeting pediatrics with acute lymphoblastic leukemia" (2019) (0)
- Amsa/ARA-C Followed By TBI 4 Gy or High Dose Chemotherapy Conditioning Regimens in Primary Refractory AML - Significantly Worse Outcomes in Younger Patients Conditioned with 4 Gy TBI (2022) (0)
- Improved Post-Transplant Outcomes in Recent Years for AML Patients with Intermediate Karyotype, FLT3-ITD and Wild Type NPM1: A Report from the EBMT Acute Leukemia Working Party (2022) (0)
- Long-Term Outcome of Second Allogeneic Stem Cell Transplantation (HSCT2) for Primary Graft Failure in Patients with Acute Leukemia in Remission: A Study on Behalf of the Acute Leukemia Working Party of the European Society for Blood and Marrow Transplantation (2022) (0)
- 512. The Cytokine Release Syndrome Crucially Contributes to the Anti-Leukemic Effects of CD44v6 CAR-T Cells (2016) (0)
- 27. Aberrant Expression of the Stem Cell microRNA-126 Induces B Cell Malignancy (2015) (0)
- allogeneic stem-cell transplantation engineered donor lymphocytes after - Antitumor effects of HSV-TK (2013) (0)
- Elastic Properties of the Tagish Lake Fall (C2, Ungrouped) (2019) (0)
- R-CHOP preceded by blood-brain barrier permeabilization (BBBp) by NGR-tumor necrosis factor (NGR-hTNF) in patients with relapsed or refractory primary CNS lymphoma (rrPCNSL): First results of the “INGRID” phase II trial. (2018) (0)
- SETD2 Non-Genomic Loss of Function and p53 Functional Inactivation in Advanced Systemic Mastocytosis (SM): Pathogenetic and Therapeutic Implications (2017) (0)
- An Analysis of the Worldwide Utilization of Hematopoietic Stem Cell Transplantation for Acute Myeloid Leukemia. (2022) (0)
- Theoretical Availability of UCBT in High Body Weight Patients Who Received Haplo-SCT for High Risk Haematological Malignancies: Results of the Simulation of Search through BMDW According to International Guidelines (2008) (0)
- Outcomes of Allogeneic Hematopoietic Cell Transplantation with Cord Blood Versus Mismatched Unrelated Donor with Post-Transplant Cyclophosphamide in Acute Myeloid Leukemia: An Analysis from the ALWP of the EBMT (2020) (0)
- ANTI-CMV Immunoglobulins in Association with ANTI-CMV Drugs in Patients with Hematological Malignancies Submitted to Allogeneic STEM CELL Transplantation: A MULTI-Center Retrospective Experience (2018) (0)
- Comparison of Transplant Outcomes in Patients with Acute Lymphoblastic Leukemia after Haploidentical Transplant with Post-Transplant Cyclophosphamide or Matched Unrelated Donor Transplant (2020) (0)
- Integrated Genomic, Functional and Prognostic Characterization of Atypical Chronic Myeloid Leukemia (aCML) in a Cohort of 43 Patients (2019) (0)
- Lentiviral haematopoietic stem cell gene therapy for metachromatic leukodystrophy: Results in nine patients treated with a cryopreserved formulation of OTL-200 (2021) (0)
- Immune signature drives leukemia escape and relapse after hematopoietic cell transplantation (2019) (0)
- Preexisting diabetes and COVID-associated hyperglycaemia in patients with COVID-19 pneumonia (2021) (0)
- Comparison of haplo-identical versus unrelated allogeneic stem cell transplantation for acute myeloid leukemia with active disease: A report of 1578 patients from Acute Leukemia Working Party of EBMT (2016) (0)
- Bifunctional nanoparticles for surface-enhanced Raman spectroscopy-based leukemia biomarker detection (2014) (0)
- THU0038 Increase of circulating memory b cells after glucocorticoid-induced remission identifies patients at risk of igg4-related disease relapse (2018) (0)
- Overall Survival Improvement Following ALLO-SCT in Patients Older THAN 60 YEARS: A Gruppo Italiano Trapianto DI Midollo Osseo (GITMO) Registry Study (2021) (0)
- Outcomes of Mismatched Related Allogeneic Stem Cell Transplantation for Chronic Lymphocytic Leukemia: A Retrospective Study on Behalf of the Chronic Malignancies Working Party of the EBMT (2016) (0)
- Minimal Residual Disease Status in Acute Myeloid Leukemia Patients Undergoing T-Cell Replete Haploidentical Transplantation. an Analysis From the Acute Leukemia Working Party (ALWP) of the European Society for Blood and Marrow Transplantation (Ebmt) (2018) (0)
- Outcomes of Allogeneic Hematopoietic Stem Cell Transplantation from Different Donor Types in Primary Refractory Acute Myeloid Leukemia: A Report from the ALWP of the EBMT (2022) (0)
- Management of Acute Leukemia Relapse After Allogeneic Hematopoietic Stem Cell Transplantation: Comparison of Different Salvage Strategies (2011) (0)
- The elusive role of proton pump inhibitors in COVID-19: Can plasma Chromogranin A levels hold the key? (2022) (0)
- Raman microspectroscopy enables the identification of different cell subpopulations in Acute Leukemia patients (2014) (0)
- Impact of disease burden on clinical outcomes of AML patients receiving allogeneic hematopoietic cell transplantation: a study from the Acute Leukemia Working Party of the European Society for Blood and Marrow Transplantation. (2023) (0)
- Profiling patients with high-risk myelodysplastic syndromes who prefer to receive survival prognostic information (2013) (0)
- Standardized Long-Term Follow-up after Allogeneic Stem Cell Transplantation: A Cross-Sectional 1-Year Evaluation in 260 Adults (2015) (0)
- Perspectives and Emotional Experiences of Patients With Chronic Myeloid Leukemia During ENESTPath Clinical Trial and Treatment-Free Remission: Rationale and Protocol of the Italian Substudy (2021) (0)
- How to Monitor Immune Reconstitution Following Allogeneic Hematopoietic Stem Cell Transplantation: A Survey from the EBMT- Cellular Therapy & Immunobiology Working Party (2016) (0)
- Unmanipulated Graft Haploindentical Allogeneic Stem Cell Transplantation (Haplo-SCT) In Acute Leukemia: A Long-Term Follow-Up Survey On Behalf Of The Acute Leukemia Working Party (ALWP) Of The European Group For Blood and Marrow Transplantation (EBMT) (2013) (0)
- Non-Linear Clonal Evolution Of Leukemia Driven By Selective Immune Pressure and Revealed By HLA Typing and High-Depth Exome Sequencing (2013) (0)
- Haploidentical stem cell transplantation abrogates the prognostic impact of FLT3-ITD in acute myeloid leukemia. A report from the Acute Leukemia Working Party of the EBMT (0)
- Establishing a National Network of Laboratories Using Next Generation Amplicon Deep Sequencing for BCR-ABL1 Kinase Domain Mutation Screening in Philadelphia Chromosome-Positive Leukemias: the ‘NEXT-IN-CML' Study (2017) (0)
- Cardiovascular Risk: Analysis of Known Factors in Patients After Treosulfan-Based Conditioning for Haploidentical and HLA-Identical Stem Cell Transplantation (2011) (0)
- MOLECULAR PROLIFE BY NEXT GENERATION SEQUENCING OF ACUTE MYELOID LEUKEMIA WITH NORMAL KARYOTYPE: CLINICAL RESULTS FROM THE PROSPECTIVE TRIAL 02/06 OF THE NORTHERN ITALY LEUKEMIA GROUP (NILG) (2018) (0)
- TCR Gene Editing Achieved In a Single Round Of T Cell Activation Is Sufficient To Redirect T Cell Specificity and Prevent GvHD (2013) (0)
- Long-Term Safety and Efficacy of Stem Cell Gene Therapy for ADA-SCID. (2006) (0)
- Post-Transplant Cyclophosphamide and Sirolimus in Matched Related and Unrelated Allogeneic Transplant with a Treosulfan-Based Conditioning (2018) (0)
- TEM-MM-101: A Phase I/IIa Dose Escalation Study Evaluating the Safety and Activity of Autologous CD34+ Enriched Hematopoietic Progenitor Cells Genetically Modified for Human Interferon-α2 in Multiple Myeloma Patients with Early Relapse after Intensive Front Line Therapy (2019) (0)
- Analysis of outcomes in patients with myeloma who had a second allohct EITHER for disease relapse or graft failure: AN EBMT CMWP study (2019) (0)
- Author Correction: Complement as a target in COVID-19? (2020) (0)
This paper list is powered by the following services:
What Schools Are Affiliated With Fabio Ciceri?
Fabio Ciceri is affiliated with the following schools:
